,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1305444,24085,Comparative Toxicogenomics Database (CTD),Mercuric Chloride,D008627,Mercuric Chloride,https://ctdbase.org/detail.go?type=chem&acc=D008627,58116,OR42E1,https://ctdbase.org/detail.go?type=gene&acc=58116,,,58116.0,or42e1,7955,Danio rerio (zebrafish),Mercuric chloride affects the expression of OR42E1 mRNA,,,PMID:20353558,https://www.ncbi.nlm.nih.gov/pubmed/20353558,20353558,,
1,1306517,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,9606,Homo sapiens (human),Silicon dioxide analog results in decreased expression of PTX3 mRNA,,,PMID:23806026,https://www.ncbi.nlm.nih.gov/pubmed/23806026,23806026,,
2,1306518,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,9606,Homo sapiens (human),Silicon dioxide analog results in increased expression of PTX3 mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
3,1306519,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,9606,Homo sapiens (human),Silicon dioxide results in increased expression of PTX3 mRNA,,,PMID:25351596,https://www.ncbi.nlm.nih.gov/pubmed/25351596,25351596,,
4,1308576,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,125950,RAVER1,https://ctdbase.org/detail.go?type=gene&acc=125950,,,125950.0,RAVER1,9606,Homo sapiens (human),Silicon dioxide results in increased expression of RAVER1 mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
5,1308577,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5930,RBBP6,https://ctdbase.org/detail.go?type=gene&acc=5930,,,5930.0,RBBP6,9606,Homo sapiens (human),Silicon dioxide results in increased expression of RBBP6 mRNA,,,PMID:25351596,https://www.ncbi.nlm.nih.gov/pubmed/25351596,25351596,,
6,1308578,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,5930,RBBP6,https://ctdbase.org/detail.go?type=gene&acc=5930,,,5930.0,RBBP6,10090,Mus musculus (house mouse),Silicon dioxide results in decreased expression of RBBP6 mRNA,,,PMID:19073995,https://www.ncbi.nlm.nih.gov/pubmed/19073995,19073995,,
7,1308579,24261,Comparative Toxicogenomics Database (CTD),Silicon Dioxide,D012822,Silicon Dioxide,https://ctdbase.org/detail.go?type=chem&acc=D012822,10616,RBCK1,https://ctdbase.org/detail.go?type=gene&acc=10616,,,10616.0,RBCK1,9606,Homo sapiens (human),Silicon dioxide analog results in increased expression of RBCK1 mRNA,,,PMID:25895662,https://www.ncbi.nlm.nih.gov/pubmed/25895662,25895662,,
8,1312792,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,2917,GRM7,https://ctdbase.org/detail.go?type=gene&acc=2917,,,2917.0,GRM7,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of GRM7 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
9,1312793,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,284110,GSDMA,https://ctdbase.org/detail.go?type=gene&acc=284110,,,284110.0,GSDMA,10090,Mus musculus (house mouse),Potassium dichromate results in increased expression of GSDMA mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
10,1312794,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,1687,GSDME,https://ctdbase.org/detail.go?type=gene&acc=1687,,,1687.0,GSDME,9606,Homo sapiens (human),Potassium dichromate results in increased expression of GSDME protein,,,PMID:23718831,https://www.ncbi.nlm.nih.gov/pubmed/23718831,23718831,,
11,1312795,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,2934,GSN,https://ctdbase.org/detail.go?type=gene&acc=2934,,,2934.0,GSN,9606,Homo sapiens (human),Potassium dichromate results in increased expression of GSN protein,,,PMID:23718831,https://www.ncbi.nlm.nih.gov/pubmed/23718831,23718831,,
12,1312796,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,7957,Carassius auratus (goldfish),Potassium dichromate results in increased activity of GSR protein,,,PMID:18304661,https://www.ncbi.nlm.nih.gov/pubmed/18304661,18304661,,
13,1312797,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Potassium dichromate results in decreased activity of GSR protein,,,PMID:21681464|PMID:29665407,https://www.ncbi.nlm.nih.gov/pubmed/21681464|https://www.ncbi.nlm.nih.gov/pubmed/29665407,21681464|29665407,,
14,1312798,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606,Homo sapiens (human),Protocatechualdehyde inhibits the reaction [potassium dichromate results in decreased activity of GSR protein],,,PMID:29665407,https://www.ncbi.nlm.nih.gov/pubmed/29665407,29665407,,
15,1317182,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,29995,LMCD1,https://ctdbase.org/detail.go?type=gene&acc=29995,,,29995.0,LMCD1,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of LMCD1 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
16,1317183,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,4000,LMNA,https://ctdbase.org/detail.go?type=gene&acc=4000,,,4000.0,LMNA,9606,Homo sapiens (human),Potassium dichromate results in increased expression of LMNA protein,,,PMID:23718831,https://www.ncbi.nlm.nih.gov/pubmed/23718831,23718831,,
17,1317184,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,55885,LMO3,https://ctdbase.org/detail.go?type=gene&acc=55885,,,55885.0,LMO3,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of LMO3 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
18,1317185,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,8543,LMO4,https://ctdbase.org/detail.go?type=gene&acc=8543,,,8543.0,LMO4,9606,Homo sapiens (human),Potassium dichromate results in increased expression of LMO4 mRNA,,,PMID:11678601,https://www.ncbi.nlm.nih.gov/pubmed/11678601,11678601,,
19,1317186,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,4015,LOX,https://ctdbase.org/detail.go?type=gene&acc=4015,,,4015.0,LOX,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of LOX mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
20,1317187,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,4016,LOXL1,https://ctdbase.org/detail.go?type=gene&acc=4016,,,4016.0,LOXL1,10090,Mus musculus (house mouse),Potassium dichromate results in increased expression of LOXL1 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
21,1317188,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,84171,LOXL4,https://ctdbase.org/detail.go?type=gene&acc=84171,,,84171.0,LOXL4,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of LOXL4 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
22,1318331,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,406937,MIR145,https://ctdbase.org/detail.go?type=gene&acc=406937,,,406937.0,MIR145,10090,Mus musculus (house mouse),Potassium dichromate results in decreased expression of MIR145 mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
23,1318332,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,7227,Drosophila melanogaster (fruit fly),Potassium dichromate results in increased expression of MLH1 mRNA,,,PMID:23628323,https://www.ncbi.nlm.nih.gov/pubmed/23628323,23628323,,
24,1318333,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,6945,MLX,https://ctdbase.org/detail.go?type=gene&acc=6945,,,6945.0,MLX,10090,Mus musculus (house mouse),Potassium dichromate results in increased expression of MLX mRNA,,,PMID:23608068,https://www.ncbi.nlm.nih.gov/pubmed/23608068,23608068,,
25,1318334,24502,Comparative Toxicogenomics Database (CTD),Potassium Dichromate,D011192,Potassium Dichromate,https://ctdbase.org/detail.go?type=chem&acc=D011192,326625,MMAB,https://ctdbase.org/detail.go?type=gene&acc=326625,,,326625.0,MMAB,9606,Homo sapiens (human),Potassium dichromate results in increased expression of MMAB protein,,,PMID:23718831,https://www.ncbi.nlm.nih.gov/pubmed/23718831,23718831,,
26,1307835,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,79036,KXD1,https://ctdbase.org/detail.go?type=gene&acc=79036,,,79036.0,KXD1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of KXD1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of KXD1 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of KXD1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
27,1307836,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,79036,KXD1,https://ctdbase.org/detail.go?type=gene&acc=79036,,,79036.0,KXD1,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of KXD1 mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
28,1307837,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,339855,KY,https://ctdbase.org/detail.go?type=gene&acc=339855,,,339855.0,KY,10090,Mus musculus (house mouse),Ozone results in decreased expression of KY mRNA,,,PMID:33026818,https://www.ncbi.nlm.nih.gov/pubmed/33026818,33026818,,
29,1307838,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,8942,KYNU,https://ctdbase.org/detail.go?type=gene&acc=8942,,,8942.0,KYNU,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of KYNU mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of KYNU mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
30,1307839,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,30634,L1CAMA,https://ctdbase.org/detail.go?type=gene&acc=30634,,,30634.0,l1cama,90988,Pimephales promelas (fathead minnow),"[water pollutants, chemical co-treated with ozone] results in decreased expression of L1CAMA mRNA",,,PMID:23246600,https://www.ncbi.nlm.nih.gov/pubmed/23246600,23246600,,
31,1307840,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,79944,L2HGDH,https://ctdbase.org/detail.go?type=gene&acc=79944,,,79944.0,L2HGDH,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of L2HGDH mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
32,1308438,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,151534,LBX2-AS1,https://ctdbase.org/detail.go?type=gene&acc=151534,,,151534.0,LBX2-AS1,9606,Homo sapiens (human),[[ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mrna] which results in increased expression of LBX2 mrna|[[ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mrna] which results in increased expression of TLX2 mrna|[ozone results in increased oxidation of dimethylselenide] which results in increased expression of LBX2-AS1 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
33,1308439,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,167691,LCA5,https://ctdbase.org/detail.go?type=gene&acc=167691,,,167691.0,LCA5,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of LCA5 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
34,1308440,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,3931,LCAT,https://ctdbase.org/detail.go?type=gene&acc=3931,,,3931.0,LCAT,10116,Rattus norvegicus (Norway rat),[ozone co-treated with chlorine] affects the expression of LCAT mRNA,,,PMID:18636392,https://www.ncbi.nlm.nih.gov/pubmed/18636392,18636392,,
35,1312636,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7975,MAFK,https://ctdbase.org/detail.go?type=gene&acc=7975,,,7975.0,MAFK,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which affects the expression of MAFK mRNA,,,PMID:35430440,https://www.ncbi.nlm.nih.gov/pubmed/35430440,35430440,,
36,1312637,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7975,MAFK,https://ctdbase.org/detail.go?type=gene&acc=7975,,,7975.0,MAFK,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of MAFK mrna|[air pollutants results in increased abundance of ozone] which results in decreased expression of MAFK mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
37,1312638,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,57692,MAGEE1,https://ctdbase.org/detail.go?type=gene&acc=57692,,,57692.0,MAGEE1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of MAGEE1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
38,1312639,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,9863,MAGI2,https://ctdbase.org/detail.go?type=gene&acc=9863,,,9863.0,MAGI2,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of MAGI2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
39,1312640,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,260425,MAGI3,https://ctdbase.org/detail.go?type=gene&acc=260425,,,260425.0,MAGI3,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of MAGI3 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
40,1312641,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,79917,MAGIX,https://ctdbase.org/detail.go?type=gene&acc=79917,,,79917.0,MAGIX,10090,Mus musculus (house mouse),Ozone results in decreased expression of MAGIX mRNA,,,PMID:17460151,https://www.ncbi.nlm.nih.gov/pubmed/17460151,17460151,,
41,1312642,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,79568,MAIP1,https://ctdbase.org/detail.go?type=gene&acc=79568,,,79568.0,MAIP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of MAIP1 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of MAIP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of MAIP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
42,1312643,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4118,MAL,https://ctdbase.org/detail.go?type=gene&acc=4118,,,4118.0,MAL,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in increased expression of MAL mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of MAL mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
43,1312994,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4123,MAN2C1,https://ctdbase.org/detail.go?type=gene&acc=4123,,,4123.0,MAN2C1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of MAN2C1 mrna|[volatile organic compounds co-treated with ozone] results in increased oxidation of MAN2C1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of MAN2C1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
44,1312995,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4123,MAN2C1,https://ctdbase.org/detail.go?type=gene&acc=4123,,,4123.0,MAN2C1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of MAN2C1 mrna|[air pollutants results in increased abundance of ozone] which results in decreased expression of MAN2C1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
45,1312996,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,7873,MANF,https://ctdbase.org/detail.go?type=gene&acc=7873,,,7873.0,MANF,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of MANF mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
46,1313977,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,51257,MARCHF2,https://ctdbase.org/detail.go?type=gene&acc=51257,,,51257.0,MARCHF2,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of MARCHF2 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of MARCHF2 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
47,1313978,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,57574,MARCHF4,https://ctdbase.org/detail.go?type=gene&acc=57574,,,57574.0,MARCHF4,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of ozone] which results in decreased expression of MARCHF4 mrna|[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in decreased expression of MARCHF4 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
48,1313979,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,10116,Rattus norvegicus (Norway rat),Ozone results in decreased expression of MARCKS mRNA,,,PMID:16330353,https://www.ncbi.nlm.nih.gov/pubmed/16330353,16330353,,
49,1313980,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,65108,MARCKSL1,https://ctdbase.org/detail.go?type=gene&acc=65108,,,65108.0,MARCKSL1,10090,Mus musculus (house mouse),[air pollutants results in increased abundance of [ozone co-treated with soot]] which results in increased expression of MARCKSL1 mRNA,,,PMID:34911549,https://www.ncbi.nlm.nih.gov/pubmed/34911549,34911549,,
50,1315160,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,90550,MCU,https://ctdbase.org/detail.go?type=gene&acc=90550,,,90550.0,MCU,9606,Homo sapiens (human),[volatile organic compounds co-treated with ozone] results in increased oxidation of MCU mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of MCU mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of MCU mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
51,1318025,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4314,MMP3,https://ctdbase.org/detail.go?type=gene&acc=4314,,,4314.0,MMP3,10116,Rattus norvegicus (Norway rat),Ozone results in increased expression of MMP3 mRNA,,,PMID:20980218,https://www.ncbi.nlm.nih.gov/pubmed/20980218,20980218,,
52,1318026,24823,Comparative Toxicogenomics Database (CTD),Ozone,D010126,Ozone,https://ctdbase.org/detail.go?type=chem&acc=D010126,4317,MMP8,https://ctdbase.org/detail.go?type=gene&acc=4317,,,4317.0,MMP8,9606,Homo sapiens (human),[air pollutants results in increased abundance of ozone] which results in increased expression of MMP8 mRNA,,,PMID:26035830,https://www.ncbi.nlm.nih.gov/pubmed/26035830,26035830,,
53,1307832,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of CSF1 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
54,1307833,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of CSF1R mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
55,1307834,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,1437,CSF2,https://ctdbase.org/detail.go?type=gene&acc=1437,,,1437.0,CSF2,9606,Homo sapiens (human),[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased secretion of CSF2 protein|sodium bichromate inhibits the reaction [[ionomycin co-treated with tetradecanoylphorbol acetate] results in increased secretion of CSF2 protein],,,PMID:17685462,https://www.ncbi.nlm.nih.gov/pubmed/17685462,17685462,,
56,1308432,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] affects the expression of EHD3 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
57,1308433,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,10919,EHMT2,https://ctdbase.org/detail.go?type=gene&acc=10919,,,10919.0,EHMT2,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in decreased expression of EHMT2 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
58,1308434,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,9538,EI24,https://ctdbase.org/detail.go?type=gene&acc=9538,,,9538.0,EI24,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of EI24 mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
59,1308435,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,10209,EIF1,https://ctdbase.org/detail.go?type=gene&acc=10209,,,10209.0,EIF1,10090,Mus musculus (house mouse),[methylnitronitrosoguanidine co-treated with tetradecanoylphorbol acetate] results in increased expression of EIF1 mRNA,,,PMID:19840844,https://www.ncbi.nlm.nih.gov/pubmed/19840844,19840844,,
60,1308436,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,1964,EIF1AX,https://ctdbase.org/detail.go?type=gene&acc=1964,,,1964.0,EIF1AX,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of EIF1AX mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
61,1308437,27924,Comparative Toxicogenomics Database (CTD),Phorbol 12-myristate 13-acetate,D013755,Tetradecanoylphorbol Acetate,https://ctdbase.org/detail.go?type=chem&acc=D013755,10289,EIF1B,https://ctdbase.org/detail.go?type=gene&acc=10289,,,10289.0,EIF1B,9986,Oryctolagus cuniculus (rabbit),[tetradecanoylphorbol acetate co-treated with ionomycin] results in increased expression of EIF1B mRNA,,,PMID:25613284,https://www.ncbi.nlm.nih.gov/pubmed/25613284,25613284,,
62,1307051,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Allopurinol inhibits the reaction [streptozocin results in increased expression of IL6 protein]|acetylcysteine inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:21912612,https://www.ncbi.nlm.nih.gov/pubmed/21912612,21912612,,
63,1307052,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Caryophyllene inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:26748309,https://www.ncbi.nlm.nih.gov/pubmed/26748309,26748309,,
64,1307053,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Crocin inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:29409856,https://www.ncbi.nlm.nih.gov/pubmed/29409856,29409856,,
65,1307054,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Curcumin inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:24760747,https://www.ncbi.nlm.nih.gov/pubmed/24760747,24760747,,
66,1307055,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),[dietary fats co-treated with streptozocin co-treated with quercetin] affects the expression of IL6 mrna|[dietary fats co-treated with streptozocin co-treated with plant extracts] affects the expression of IL6 protein|[dietary fats co-treated with streptozocin co-treated with quercetin] affects the expression of IL6 protein,,,PMID:21439094,https://www.ncbi.nlm.nih.gov/pubmed/21439094,21439094,,
67,1307056,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Diosgenin inhibits the reaction [streptozocin results in increased expression of IL6 mrna]|diosgenin inhibits the reaction [streptozocin results in increased expression of IL6 protein],,,PMID:35305976,https://www.ncbi.nlm.nih.gov/pubmed/35305976,35305976,,
68,1311915,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,387236,MIR125B-1,https://ctdbase.org/detail.go?type=gene&acc=387236,,,387236.0,Mir125b-1,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR125B-1 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
69,1311916,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,406915,MIR128-1,https://ctdbase.org/detail.go?type=gene&acc=406915,,,406915.0,MIR128-1,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR128-1 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
70,1311917,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,100302153,MIR1298,https://ctdbase.org/detail.go?type=gene&acc=100302153,,,100302153.0,MIR1298,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR1298 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
71,1312483,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,100126296,MIR298,https://ctdbase.org/detail.go?type=gene&acc=100126296,,,100126296.0,MIR298,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR298 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
72,1312484,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,407021,MIR29A,https://ctdbase.org/detail.go?type=gene&acc=407021,,,407021.0,MIR29A,10090,Mus musculus (house mouse),MIR29A mRNA inhibits the reaction [streptozocin results in increased expression of IL6 mrna]|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of COL4A2 mrna]|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of TNF mrna]|mir29a mRNA inhibits the reaction [streptozocin results in decreased expression of PPARG protein]|streptozocin results in decreased expression of MIR29A mrna|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of CNR1 protein]|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of IL1B protein]|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of JUN mrna]|mir29a mRNA inhibits the reaction [streptozocin results in increased expression of CNR1 mrna]|mir29a mRNA inhibits the reaction [streptozocin results in decreased expression of PPARG mrna],,,PMID:30642005,https://www.ncbi.nlm.nih.gov/pubmed/30642005,30642005,,
73,1312485,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,407026,MIR29C,https://ctdbase.org/detail.go?type=gene&acc=407026,,,407026.0,MIR29C,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR29C mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
74,1312486,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,407028,MIR302A,https://ctdbase.org/detail.go?type=gene&acc=407028,,,407028.0,MIR302A,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR302A mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
75,1312487,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,442895,MIR302C,https://ctdbase.org/detail.go?type=gene&acc=442895,,,442895.0,MIR302C,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR302C mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
76,1312488,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,113839519,MIR3059,https://ctdbase.org/detail.go?type=gene&acc=113839519,,,113839519.0,MIR3059,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR3059 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
77,1312489,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,100526466,MIR3060,https://ctdbase.org/detail.go?type=gene&acc=100526466,,,100526466.0,Mir3060,10090,Mus musculus (house mouse),Streptozocin results in decreased expression of MIR3060 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
78,1312490,29327,Comparative Toxicogenomics Database (CTD),Streptozocin,D013311,Streptozocin,https://ctdbase.org/detail.go?type=chem&acc=D013311,100526468,MIR3063,https://ctdbase.org/detail.go?type=gene&acc=100526468,,,100526468.0,Mir3063,10090,Mus musculus (house mouse),Streptozocin results in increased expression of MIR3063 mRNA,,,PMID:27629361,https://www.ncbi.nlm.nih.gov/pubmed/27629361,27629361,,
79,1313473,30699,DrugBank,Cephapirin,DB01139,Cefapirin,https://www.drugbank.ca/drugs/DB01139,BE0000576,Penicillin-binding protein 1A,https://www.drugbank.ca/bio_entities/BE0000576,Q8XJ01,Penicillin-binding protein 1A,,,195102,Clostridium perfringens str. 13,Inhibitor,,,PMID:17139284|PMID:17016423|PMID:808545,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/808545,17139284|17016423|808545,,
80,1313474,30751,Toxin and Toxin Target Database (T3DB),Fludarabine Phosphate,T3D4736,Fludarabine,http://www.t3db.ca/toxins/T3D4736,BE0000546,DNA polymerase alpha catalytic subunit,http://www.t3db.ca/biodb/bio_entities/BE0000546,P09884,DNA polymerase alpha catalytic subunit,5422.0,POLA1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:19519505|PMID:19325518|PMID:17168705,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/19519505|https://www.ncbi.nlm.nih.gov/pubmed/19325518|https://www.ncbi.nlm.nih.gov/pubmed/17168705,17139284|17016423|19519505|19325518|17168705,,
81,1313475,30751,Toxin and Toxin Target Database (T3DB),Fludarabine Phosphate,T3D4736,Fludarabine,http://www.t3db.ca/toxins/T3D4736,BE0000325,Ribonucleoside-diphosphate reductase large subunit,http://www.t3db.ca/biodb/bio_entities/BE0000325,P23921,Ribonucleoside-diphosphate reductase large subunit,6240.0,RRM1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:19519505|PMID:19325518,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/19519505|https://www.ncbi.nlm.nih.gov/pubmed/19325518,17139284|17016423|19519505|19325518,,
82,1313476,30751,Toxin and Toxin Target Database (T3DB),Fludarabine Phosphate,T3D4736,Fludarabine,http://www.t3db.ca/toxins/T3D4736,BE0002804,Deoxycytidine kinase,http://www.t3db.ca/biodb/bio_entities/BE0002804,P27707,Deoxycytidine kinase,1633.0,DCK,9606,Homo sapiens (human),,,,PMID:15820918|PMID:20137114|PMID:16421443,https://www.ncbi.nlm.nih.gov/pubmed/15820918|https://www.ncbi.nlm.nih.gov/pubmed/20137114|https://www.ncbi.nlm.nih.gov/pubmed/16421443,15820918|20137114|16421443,,
83,1313477,31036,BindingDB,4-((2-Amino-4-pyrimidinyl)amino)benzenesulfonamide,10873,4-[(2-aminopyrimidin-4-yl)amino]benzene-1-sulfonamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10873,1229,"Carbonic anhydrase 5B, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1229,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606,Homo sapiens (human),,Ki (nM),10200.0,PMID:16302824|DOI:10.1021/jm050483n,https://www.ncbi.nlm.nih.gov/pubmed/16302824|https://doi.org/10.1021/jm050483n,16302824,10.1021/jm050483n,
84,1313981,31101,Drug Gene Interaction database (DGIdb),Bromocriptine,,SKF-38393,https://www.dgidb.org/drugs/iuphar.ligand:935,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606,Homo sapiens (human),,,,,,,,
85,1313982,31193,IUPHAR/BPS Guide to PHARMACOLOGY,Cadmium cation,2440,Cd2+,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2440,534,Cav2.3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=534,Q15878,Voltage-dependent R-type calcium channel subunit alpha-1E,777.0,CACNA1E,9606,Homo sapiens (human),Antagonist,pIC50,6.1,PMID:8071363,https://www.ncbi.nlm.nih.gov/pubmed/8071363,8071363,,
86,1313983,31193,IUPHAR/BPS Guide to PHARMACOLOGY,Cadmium cation,2440,Cd2+,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2440,528,Cav1.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=528,Q02485,Voltage-dependent L-type calcium channel subunit alpha-1S,682930.0,Cacna1s,10116,Rattus norvegicus (Norway rat),Antagonist,pIC50,4.3,PMID:2458429,https://www.ncbi.nlm.nih.gov/pubmed/2458429,2458429,,
87,1313984,31193,IUPHAR/BPS Guide to PHARMACOLOGY,Cadmium cation,2440,Cd2+,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2440,584,Nav1.7,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=584,Q15858,Sodium channel protein type 9 subunit alpha,6335.0,SCN9A,9606,Homo sapiens (human),Pore blocker,pIC50,3.0,PMID:7720699,https://www.ncbi.nlm.nih.gov/pubmed/7720699,7720699,,
88,1313985,31193,IUPHAR/BPS Guide to PHARMACOLOGY,Cadmium cation,2440,Cd2+,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2440,575,Kv12.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=575,P59111,Potassium voltage-gated channel subfamily H member 8,211468.0,Kcnh8,10090,Mus musculus (house mouse),,,3.7,PMID:19580749,https://www.ncbi.nlm.nih.gov/pubmed/19580749,19580749,,
89,1316982,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10090,Mus musculus (house mouse),Pyrene results in increased expression of and results in increased activity of SULT1A1 protein,,,PMID:17618724,https://www.ncbi.nlm.nih.gov/pubmed/17618724,17618724,,
90,1316983,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10090,Mus musculus (house mouse),Pyrene results in increased expression of SULT1A1 mRNA,,,PMID:17618724|PMID:26160115,https://www.ncbi.nlm.nih.gov/pubmed/17618724|https://www.ncbi.nlm.nih.gov/pubmed/26160115,17618724|26160115,,
91,1316984,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,338214,SULT2ST1,https://ctdbase.org/detail.go?type=gene&acc=338214,,,338214.0,sult2st1,7955,Danio rerio (zebrafish),Pyrene results in decreased expression of SULT2ST1 mRNA,,,PMID:23656968,https://www.ncbi.nlm.nih.gov/pubmed/23656968,23656968,,
92,1316985,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,393236,SYBL1,https://ctdbase.org/detail.go?type=gene&acc=393236,,,393236.0,sybl1,35525,Daphnia magna,[fluoranthene co-treated with pyrene] results in decreased expression of SYBL1 mRNA,,,PMID:20117838,https://www.ncbi.nlm.nih.gov/pubmed/20117838,20117838,,
93,1316986,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,25771,TBC1D22A,https://ctdbase.org/detail.go?type=gene&acc=25771,,,25771.0,TBC1D22A,7955,Danio rerio (zebrafish),Pyrene results in increased expression of TBC1D22A mRNA,,,PMID:23656968,https://www.ncbi.nlm.nih.gov/pubmed/23656968,23656968,,
94,1316987,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,387332,TBPL2,https://ctdbase.org/detail.go?type=gene&acc=387332,,,387332.0,TBPL2,7955,Danio rerio (zebrafish),Pyrene results in decreased expression of TBPL2 mRNA,,,PMID:23656968,https://www.ncbi.nlm.nih.gov/pubmed/23656968,23656968,,
95,1316988,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,8022,Oncorhynchus mykiss (rainbow trout),Pyrene results in increased expression of TF mrna|pyrene results in decreased expression of TF mRNA,,,PMID:15963578,https://www.ncbi.nlm.nih.gov/pubmed/15963578,15963578,,
96,1316989,31423,Comparative Toxicogenomics Database (CTD),Pyrene,C030984,pyrene,https://ctdbase.org/detail.go?type=chem&acc=C030984,447909,TGM2A,https://ctdbase.org/detail.go?type=gene&acc=447909,,,447909.0,tgm2a,7955,Danio rerio (zebrafish),Pyrene results in decreased expression of TGM2A mRNA,,,PMID:23656968,https://www.ncbi.nlm.nih.gov/pubmed/23656968,23656968,,
97,1306712,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1760,DMPK,https://ctdbase.org/detail.go?type=gene&acc=1760,,,1760.0,DMPK,9606,Homo sapiens (human),Doxorubicin results in decreased expression of DMPK mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
98,1306713,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,2039,DMTN,https://ctdbase.org/detail.go?type=gene&acc=2039,,,2039.0,DMTN,9606,Homo sapiens (human),Doxorubicin results in decreased expression of DMTN mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
99,1306714,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,1657,DMXL1,https://ctdbase.org/detail.go?type=gene&acc=1657,,,1657.0,DMXL1,9606,Homo sapiens (human),Doxorubicin results in decreased expression of DMXL1 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
100,1306715,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,23312,DMXL2,https://ctdbase.org/detail.go?type=gene&acc=23312,,,23312.0,DMXL2,9606,Homo sapiens (human),Doxorubicin results in decreased expression of DMXL2 mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
101,1314948,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,125061,AFMID,https://ctdbase.org/detail.go?type=gene&acc=125061,,,125061.0,AFMID,9606,Homo sapiens (human),Doxorubicin results in decreased expression of AFMID mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
102,1314949,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,9606,Homo sapiens (human),Doxorubicin results in decreased expression of AFP mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
103,1318492,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,84919,PPP1R15B,https://ctdbase.org/detail.go?type=gene&acc=84919,,,84919.0,PPP1R15B,9606,Homo sapiens (human),Doxorubicin results in increased expression of PPP1R15B mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
104,1318493,31703,Comparative Toxicogenomics Database (CTD),Doxorubicin,D004317,Doxorubicin,https://ctdbase.org/detail.go?type=chem&acc=D004317,84988,PPP1R16A,https://ctdbase.org/detail.go?type=gene&acc=84988,,,84988.0,PPP1R16A,9606,Homo sapiens (human),Doxorubicin results in decreased expression of PPP1R16A mRNA,,,PMID:29803840,https://www.ncbi.nlm.nih.gov/pubmed/29803840,29803840,,
105,1308045,31736,Comparative Toxicogenomics Database (CTD),Monobenzyl phthalate,C103325,mono-benzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C103325,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,10090,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ARNT mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
106,1308046,31736,Comparative Toxicogenomics Database (CTD),Monobenzyl phthalate,C103325,mono-benzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C103325,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA,,,PMID:35861251,https://www.ncbi.nlm.nih.gov/pubmed/35861251,35861251,,
107,1308047,31736,Comparative Toxicogenomics Database (CTD),Monobenzyl phthalate,C103325,mono-benzyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C103325,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090,Mus musculus (house mouse),[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA,,,PMID:31884101,https://www.ncbi.nlm.nih.gov/pubmed/31884101,31884101,,
108,1306889,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,57326,PBXIP1,https://ctdbase.org/detail.go?type=gene&acc=57326,,,57326.0,PBXIP1,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PBXIP1 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
109,1306890,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575.0,PCDH10,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PCDH10 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
110,1306891,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PCDH17 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
111,1306892,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,56113,PCDHGA2,https://ctdbase.org/detail.go?type=gene&acc=56113,,,56113.0,PCDHGA2,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PCDHGA2 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
112,1306893,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,5098,PCDHGC3,https://ctdbase.org/detail.go?type=gene&acc=5098,,,5098.0,PCDHGC3,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of PCDHGC3 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
113,1306894,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51585,PCF11,https://ctdbase.org/detail.go?type=gene&acc=51585,,,51585.0,PCF11,10090,Mus musculus (house mouse),Clobetasol results in increased expression of PCF11 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
114,1307373,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR1C mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
115,1307374,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51082,POLR1D,https://ctdbase.org/detail.go?type=gene&acc=51082,,,51082.0,POLR1D,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR1D mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
116,1307375,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,5430,POLR2A,https://ctdbase.org/detail.go?type=gene&acc=5430,,,5430.0,POLR2A,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of POLR2A mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
117,1307376,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,5438,POLR2I,https://ctdbase.org/detail.go?type=gene&acc=5438,,,5438.0,POLR2I,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR2I mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
118,1307377,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,5441,POLR2L,https://ctdbase.org/detail.go?type=gene&acc=5441,,,5441.0,POLR2L,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR2L mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
119,1307378,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,171568,POLR3H,https://ctdbase.org/detail.go?type=gene&acc=171568,,,171568.0,POLR3H,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR3H mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
120,1307379,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51728,POLR3K,https://ctdbase.org/detail.go?type=gene&acc=51728,,,51728.0,POLR3K,10090,Mus musculus (house mouse),Clobetasol results in increased expression of POLR3K mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
121,1307380,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,10450,PPIE,https://ctdbase.org/detail.go?type=gene&acc=10450,,,10450.0,PPIE,10090,Mus musculus (house mouse),Clobetasol results in increased expression of PPIE mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
122,1307381,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51645,PPIL1,https://ctdbase.org/detail.go?type=gene&acc=51645,,,51645.0,PPIL1,10090,Mus musculus (house mouse),Clobetasol results in increased expression of PPIL1 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
123,1307382,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,152926,PPM1K,https://ctdbase.org/detail.go?type=gene&acc=152926,,,152926.0,PPM1K,10090,Mus musculus (house mouse),Clobetasol results in increased expression of PPM1K mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
124,1308572,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,56681,SAR1A,https://ctdbase.org/detail.go?type=gene&acc=56681,,,56681.0,SAR1A,10090,Mus musculus (house mouse),Clobetasol results in increased expression of SAR1A mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
125,1308573,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51128,SAR1B,https://ctdbase.org/detail.go?type=gene&acc=51128,,,51128.0,SAR1B,10090,Mus musculus (house mouse),Clobetasol results in increased expression of SAR1B mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
126,1308574,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,51669,SARAF,https://ctdbase.org/detail.go?type=gene&acc=51669,,,51669.0,SARAF,10090,Mus musculus (house mouse),Clobetasol results in increased expression of SARAF mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
127,1308575,32798,Comparative Toxicogenomics Database (CTD),Clobetasol Propionate,D002990,Clobetasol,https://ctdbase.org/detail.go?type=chem&acc=D002990,23328,SASH1,https://ctdbase.org/detail.go?type=gene&acc=23328,,,23328.0,SASH1,10090,Mus musculus (house mouse),Clobetasol results in decreased expression of SASH1 mRNA,,,PMID:27462272,https://www.ncbi.nlm.nih.gov/pubmed/27462272,27462272,,
128,1315556,33113,Comparative Toxicogenomics Database (CTD),Phosphoaminophosphonic acid-adenylate ester,D000266,Adenylyl Imidodiphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000266,547,KIF1A,https://ctdbase.org/detail.go?type=gene&acc=547,,,547.0,KIF1A,9606,Homo sapiens (human),KIF1A protein binds to adenylyl imidodiphosphate,,,PMID:15286375,https://www.ncbi.nlm.nih.gov/pubmed/15286375,15286375,,
129,1315557,33113,Comparative Toxicogenomics Database (CTD),Phosphoaminophosphonic acid-adenylate ester,D000266,Adenylyl Imidodiphosphate,https://ctdbase.org/detail.go?type=chem&acc=D000266,5729,PTGDR,https://ctdbase.org/detail.go?type=gene&acc=5729,,,5729.0,PTGDR,9606,Homo sapiens (human),Adenylyl imidodiphosphate inhibits the reaction [prostaglandin D2 binds to PTGDR protein],,,PMID:9579725,https://www.ncbi.nlm.nih.gov/pubmed/9579725,9579725,,
130,1315558,33334,Comparative Toxicogenomics Database (CTD),Frentizole,C013997,frentizole,https://ctdbase.org/detail.go?type=chem&acc=C013997,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9823,Sus scrofa (pig),Frentizole results in increased activity of CS protein|frentizole analog affects the activity of CS protein,,,PMID:33359020,https://www.ncbi.nlm.nih.gov/pubmed/33359020,33359020,,
131,1315559,33334,Comparative Toxicogenomics Database (CTD),Frentizole,C013997,frentizole,https://ctdbase.org/detail.go?type=chem&acc=C013997,3028,HSD17B10,https://ctdbase.org/detail.go?type=gene&acc=3028,,,3028.0,HSD17B10,9606,Homo sapiens (human),Frentizole results in decreased activity of HSD17B10 protein,,,PMID:33359020,https://www.ncbi.nlm.nih.gov/pubmed/33359020,33359020,,
132,1315560,33334,Comparative Toxicogenomics Database (CTD),Frentizole,C013997,frentizole,https://ctdbase.org/detail.go?type=chem&acc=C013997,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128.0,MAOA,9823,Sus scrofa (pig),Frentizole analog results in decreased activity of MAOA protein,,,PMID:33359020,https://www.ncbi.nlm.nih.gov/pubmed/33359020,33359020,,
133,1315561,33334,Comparative Toxicogenomics Database (CTD),Frentizole,C013997,frentizole,https://ctdbase.org/detail.go?type=chem&acc=C013997,4129,MAOB,https://ctdbase.org/detail.go?type=gene&acc=4129,,,4129.0,MAOB,9823,Sus scrofa (pig),Frentizole analog results in decreased activity of MAOB protein,,,PMID:33359020,https://www.ncbi.nlm.nih.gov/pubmed/33359020,33359020,,
134,1315562,33334,Drug Gene Interaction database (DGIdb),Frentizole,,FRENTIZOLE,https://www.dgidb.org/drugs/ncit:C167023,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
135,1307192,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,4958,OMD,https://ctdbase.org/detail.go?type=gene&acc=4958,,,4958.0,OMD,10090,Mus musculus (house mouse),Diisodecyl phthalate results in decreased expression of OMD mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
136,1307193,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,26031,OSBPL3,https://ctdbase.org/detail.go?type=gene&acc=26031,,,26031.0,OSBPL3,10090,Mus musculus (house mouse),Diisodecyl phthalate results in decreased expression of OSBPL3 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
137,1307194,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,5020,OXT,https://ctdbase.org/detail.go?type=gene&acc=5020,,,5020.0,OXT,10090,Mus musculus (house mouse),"[diethyl phthalate co-treated with dibutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of OXT mRNA",,,PMID:32518293,https://www.ncbi.nlm.nih.gov/pubmed/32518293,32518293,,
138,1307195,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,5021,OXTR,https://ctdbase.org/detail.go?type=gene&acc=5021,,,5021.0,OXTR,10090,Mus musculus (house mouse),"[diethyl phthalate co-treated with dibutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate co-treated with bis(2-propylheptyl)phthalate co-treated with bisphenol A co-treated with 3,5,6-trichloro-2-pyridinol co-treated with 3-phenoxybenzoic acid co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of OXTR mRNA",,,PMID:32518293,https://www.ncbi.nlm.nih.gov/pubmed/32518293,32518293,,
139,1307196,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,5214,PFKP,https://ctdbase.org/detail.go?type=gene&acc=5214,,,5214.0,PFKP,10090,Mus musculus (house mouse),Diisodecyl phthalate results in increased expression of PFKP mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
140,1307197,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606,Homo sapiens (human),Diisodecyl phthalate binds to PPARA protein,,,PMID:23843199,https://www.ncbi.nlm.nih.gov/pubmed/23843199,23843199,,
141,1307549,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,6732,SRPK1,https://ctdbase.org/detail.go?type=gene&acc=6732,,,6732.0,SRPK1,10090,Mus musculus (house mouse),Diisodecyl phthalate results in increased expression of SRPK1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
142,1307550,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116,Rattus norvegicus (Norway rat),Diisodecyl phthalate results in decreased expression of STAR mrna|diisodecyl phthalate results in decreased expression of STAR protein,,,PMID:32387388,https://www.ncbi.nlm.nih.gov/pubmed/32387388,32387388,,
143,1307551,33599,Comparative Toxicogenomics Database (CTD),Diisodecyl phthalate,C042080,diisodecyl phthalate,https://ctdbase.org/detail.go?type=chem&acc=C042080,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090,Mus musculus (house mouse),Diisodecyl phthalate promotes the reaction [fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]|melatonin inhibits the reaction [diisodecyl phthalate promotes the reaction [fluorescein-5-isothiocyanate results in increased phosphorylation of STAT3 protein]],,,PMID:27871981,https://www.ncbi.nlm.nih.gov/pubmed/27871981,27871981,,
144,1307690,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit beta-2,https://www.drugbank.ca/bio_entities/BE0004797,P47870,Gamma-aminobutyric acid receptor subunit beta-2,2561.0,GABRB2,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
145,1307691,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit beta-3,https://www.drugbank.ca/bio_entities/BE0004797,P28472,Gamma-aminobutyric acid receptor subunit beta-3,2562.0,GABRB3,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
146,1307692,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit delta,https://www.drugbank.ca/bio_entities/BE0004797,O14764,Gamma-aminobutyric acid receptor subunit delta,2563.0,GABRD,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
147,1307693,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit epsilon,https://www.drugbank.ca/bio_entities/BE0004797,P78334,Gamma-aminobutyric acid receptor subunit epsilon,2564.0,GABRE,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
148,1307694,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-1,https://www.drugbank.ca/bio_entities/BE0004797,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,2565.0,GABRG1,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
149,1307695,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-2,https://www.drugbank.ca/bio_entities/BE0004797,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,2566.0,GABRG2,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
150,1307696,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit gamma-3,https://www.drugbank.ca/bio_entities/BE0004797,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
151,1307697,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit pi,https://www.drugbank.ca/bio_entities/BE0004797,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
152,1307698,33746,DrugBank,Ketazolam,DB01587,Ketazolam,https://www.drugbank.ca/drugs/DB01587,BE0004797,Gamma-aminobutyric acid receptor subunit theta,https://www.drugbank.ca/bio_entities/BE0004797,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606,Homo sapiens (human),Positive allosteric modulator,,,PMID:23038269|PMID:29950725,https://www.ncbi.nlm.nih.gov/pubmed/23038269|https://www.ncbi.nlm.nih.gov/pubmed/29950725,23038269|29950725,,
153,1312125,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,233887,ZFP553,https://ctdbase.org/detail.go?type=gene&acc=233887,,,233887.0,Zfp553,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ZFP553 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
154,1312126,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,72701,ZFP618,https://ctdbase.org/detail.go?type=gene&acc=72701,,,72701.0,Zfp618,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP618 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
155,1312127,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,55734,ZFP64,https://ctdbase.org/detail.go?type=gene&acc=55734,,,55734.0,ZFP64,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ZFP64 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
156,1312128,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,268469,ZFP652,https://ctdbase.org/detail.go?type=gene&acc=268469,,,268469.0,Zfp652,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ZFP652 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
157,1312129,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,71131,ZFP689,https://ctdbase.org/detail.go?type=gene&acc=71131,,,71131.0,Zfp689,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP689 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
158,1312130,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,76390,ZFP735,https://ctdbase.org/detail.go?type=gene&acc=76390,,,76390.0,Zfp735,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP735 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
159,1312131,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,69228,ZFP746,https://ctdbase.org/detail.go?type=gene&acc=69228,,,69228.0,Zfp746,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP746 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
160,1312132,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,319530,ZFP750,https://ctdbase.org/detail.go?type=gene&acc=319530,,,319530.0,Zfp750,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP750 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
161,1313314,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,6166,RPL36AL,https://ctdbase.org/detail.go?type=gene&acc=6166,,,6166.0,RPL36AL,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL36AL mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
162,1313315,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,100043893,RPL36A-PS3,https://ctdbase.org/detail.go?type=gene&acc=100043893,,,100043893.0,Rpl36a-ps3,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL36A-PS3 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
163,1313316,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,100502825,RPL37RT,https://ctdbase.org/detail.go?type=gene&acc=100502825,,,100502825.0,Rpl37rt,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL37RT mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
164,1313317,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,6170,RPL39,https://ctdbase.org/detail.go?type=gene&acc=6170,,,6170.0,RPL39,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL39 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
165,1313318,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,100503815,RPL39-PS,https://ctdbase.org/detail.go?type=gene&acc=100503815,,,100503815.0,Rpl39-ps,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL39-PS mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
166,1313319,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,6171,RPL41,https://ctdbase.org/detail.go?type=gene&acc=6171,,,6171.0,RPL41,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of RPL41 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
167,1313816,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,22928,SEPHS2,https://ctdbase.org/detail.go?type=gene&acc=22928,,,22928.0,SEPHS2,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of SEPHS2 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
168,1313817,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,6906,SERPINA7,https://ctdbase.org/detail.go?type=gene&acc=6906,,,6906.0,SERPINA7,9606,Homo sapiens (human),"2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SERPINA7 protein",,,PMID:19750101,https://www.ncbi.nlm.nih.gov/pubmed/19750101,19750101,,
169,1314164,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,122060,SLAIN1,https://ctdbase.org/detail.go?type=gene&acc=122060,,,122060.0,SLAIN1,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLAIN1 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
170,1314165,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,57606,SLAIN2,https://ctdbase.org/detail.go?type=gene&acc=57606,,,57606.0,SLAIN2,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLAIN2 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
171,1314166,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,6564,SLC15A1,https://ctdbase.org/detail.go?type=gene&acc=6564,,,6564.0,SLC15A1,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC15A1 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
172,1314167,35823,Comparative Toxicogenomics Database (CTD),"2,3',4,4',5-Pentachlorobiphenyl",C070055,"2,3',4,4',5-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C070055,201232,SLC16A13,https://ctdbase.org/detail.go?type=gene&acc=201232,,,201232.0,SLC16A13,10090,Mus musculus (house mouse),"2,3',4,4',5-pentachlorobiphenyl affects the expression of SLC16A13 mRNA",,,PMID:31388691,https://www.ncbi.nlm.nih.gov/pubmed/31388691,31388691,,
173,1312308,36231,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5,5'-Hexachlorobiphenyl",C027309,"3,4,5,3',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C027309,1646,AKR1C2,https://ctdbase.org/detail.go?type=gene&acc=1646,,,1646.0,AKR1C2,10116,Rattus norvegicus (Norway rat),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in decreased expression of AKR1C2 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
174,1312309,36231,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5,5'-Hexachlorobiphenyl",C027309,"3,4,5,3',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C027309,26358,ALDH1A7,https://ctdbase.org/detail.go?type=gene&acc=26358,,,26358.0,Aldh1a7,10116,Rattus norvegicus (Norway rat),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in decreased expression of ALDH1A7 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
175,1312310,36231,Comparative Toxicogenomics Database (CTD),"3,3',4,4',5,5'-Hexachlorobiphenyl",C027309,"3,4,5,3',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C027309,647219,ASCL5,https://ctdbase.org/detail.go?type=gene&acc=647219,,,647219.0,ASCL5,10116,Rattus norvegicus (Norway rat),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with dibenzofurans, polychlorinated co-treated with polychlorinated dibenzodioxins] results in increased expression of ASCL5 mRNA",,,PMID:30744511,https://www.ncbi.nlm.nih.gov/pubmed/30744511,30744511,,
176,1315737,36231,Toxin and Toxin Target Database (T3DB),"3,3',4,4',5,5'-Hexachlorobiphenyl",T3D0558,"3,3',4,4',5,5'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0558,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
177,1315738,36231,Toxin and Toxin Target Database (T3DB),"3,3',4,4',5,5'-Hexachlorobiphenyl",T3D0558,"3,3',4,4',5,5'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0558,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
178,1312311,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,1463,NCAN,https://ctdbase.org/detail.go?type=gene&acc=1463,,,1463.0,NCAN,10116,Rattus norvegicus (Norway rat),Procymidone results in increased expression of NCAN mRNA,,,PMID:15686871,https://www.ncbi.nlm.nih.gov/pubmed/15686871,15686871,,
179,1312312,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of NF1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
180,1312313,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,4784,NFIX,https://ctdbase.org/detail.go?type=gene&acc=4784,,,4784.0,NFIX,10116,Rattus norvegicus (Norway rat),Procymidone results in increased expression of NFIX mRNA,,,PMID:15686871,https://www.ncbi.nlm.nih.gov/pubmed/15686871,15686871,,
181,1312314,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,4803,NGF,https://ctdbase.org/detail.go?type=gene&acc=4803,,,4803.0,NGF,10116,Rattus norvegicus (Norway rat),Procymidone results in decreased expression of NGF mRNA,,,PMID:15686871,https://www.ncbi.nlm.nih.gov/pubmed/15686871,15686871,,
182,1312315,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,22871,NLGN1,https://ctdbase.org/detail.go?type=gene&acc=22871,,,22871.0,NLGN1,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of NLGN1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
183,1312316,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,10116,Rattus norvegicus (Norway rat),Procymidone results in decreased expression of NOS3 mRNA,,,PMID:15686871,https://www.ncbi.nlm.nih.gov/pubmed/15686871,15686871,,
184,1313133,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,6712,SPTBN2,https://ctdbase.org/detail.go?type=gene&acc=6712,,,6712.0,SPTBN2,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of SPTBN2 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
185,1313134,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090,Mus musculus (house mouse),Procymidone results in decreased expression of STAR mRNA,,,PMID:35913088,https://www.ncbi.nlm.nih.gov/pubmed/35913088,35913088,,
186,1313135,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,11075,STMN2,https://ctdbase.org/detail.go?type=gene&acc=11075,,,11075.0,STMN2,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of STMN2 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
187,1313136,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,412,STS,https://ctdbase.org/detail.go?type=gene&acc=412,,,412.0,STS,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in decreased expression of STS mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
188,1313137,36242,Comparative Toxicogenomics Database (CTD),Procymidone,C035988,procymidone,https://ctdbase.org/detail.go?type=chem&acc=C035988,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with diethylhexyl phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with linuron co-treated with epoxiconazole co-treated with dichlorodiphenyl dichloroethylene] results in increased expression of STXBP1 mRNA,,,PMID:25607892,https://www.ncbi.nlm.nih.gov/pubmed/25607892,25607892,,
189,1313650,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D000068196,Albumin-Bound Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D000068196,14991,H2-M3,https://ctdbase.org/detail.go?type=gene&acc=14991,,,14991.0,H2-M3,10090,Mus musculus (house mouse),Albumin-bound paclitaxel results in increased expression of H2-M3 mRNA,,,PMID:31249575,https://www.ncbi.nlm.nih.gov/pubmed/31249575,31249575,,
190,1313651,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D000068196,Albumin-Bound Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D000068196,15040,H2-T23,https://ctdbase.org/detail.go?type=gene&acc=15040,,,15040.0,H2-T23,10090,Mus musculus (house mouse),Albumin-bound paclitaxel results in increased expression of H2-T23 mRNA,,,PMID:31249575,https://www.ncbi.nlm.nih.gov/pubmed/31249575,31249575,,
191,1313652,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D000068196,Albumin-Bound Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D000068196,9020,MAP3K14,https://ctdbase.org/detail.go?type=gene&acc=9020,,,9020.0,MAP3K14,10090,Mus musculus (house mouse),Albumin-bound paclitaxel results in decreased expression of MAP3K14 mRNA,,,PMID:31249575,https://www.ncbi.nlm.nih.gov/pubmed/31249575,31249575,,
192,1313653,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D000068196,Albumin-Bound Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D000068196,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,10090,Mus musculus (house mouse),Albumin-bound paclitaxel results in increased expression of PSMB9 mRNA,,,PMID:31249575,https://www.ncbi.nlm.nih.gov/pubmed/31249575,31249575,,
193,1313654,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D000068196,Albumin-Bound Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D000068196,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Albumin-bound paclitaxel results in increased expression of TNF mRNA,,,PMID:31249575,https://www.ncbi.nlm.nih.gov/pubmed/31249575,31249575,,
194,1315739,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,23461,ABCA5,https://ctdbase.org/detail.go?type=gene&acc=23461,,,23461.0,ABCA5,9606,Homo sapiens (human),Paclitaxel results in increased expression of ABCA5 mRNA,,,PMID:20737486,https://www.ncbi.nlm.nih.gov/pubmed/20737486,20737486,,
195,1315740,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,10347,ABCA7,https://ctdbase.org/detail.go?type=gene&acc=10347,,,10347.0,ABCA7,9606,Homo sapiens (human),Paclitaxel results in increased expression of ABCA7 mRNA,,,PMID:20737486,https://www.ncbi.nlm.nih.gov/pubmed/20737486,20737486,,
196,1315741,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),ABCB1 protein results in increased export of paclitaxel|6-OH-BDE-47 inhibits the reaction [ABCB1 protein results in increased export of paclitaxel],,,PMID:28031414,https://www.ncbi.nlm.nih.gov/pubmed/28031414,28031414,,
197,1315742,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),ABCB1 gene polymorphism affects the metabolism of paclitaxel,,,PMID:15901749,https://www.ncbi.nlm.nih.gov/pubmed/15901749,15901749,,
198,1315743,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),ABCB1 gene SNP affects the susceptibility to paclitaxel,,,PMID:16950614,https://www.ncbi.nlm.nih.gov/pubmed/16950614,16950614,,
199,1315744,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),ABCB1 mRNA results in decreased susceptibility to paclitaxel,,,PMID:16322897,https://www.ncbi.nlm.nih.gov/pubmed/16322897,16322897,,
200,1316231,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),Vanadates inhibits the reaction [paclitaxel promotes the reaction [ABCB1 protein results in increased hydrolysis of adenosine triphosphate]]|paclitaxel promotes the reaction [ABCB1 protein results in increased hydrolysis of adenosine triphosphate],,,PMID:32212926,https://www.ncbi.nlm.nih.gov/pubmed/32212926,32212926,,
201,1316232,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,9606,Homo sapiens (human),Paclitaxel results in decreased activity of ABCB11 protein,,,PMID:20829430|PMID:23956101,https://www.ncbi.nlm.nih.gov/pubmed/20829430|https://www.ncbi.nlm.nih.gov/pubmed/23956101,20829430|23956101,,
202,1316233,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,18671,ABCB1A,https://ctdbase.org/detail.go?type=gene&acc=18671,,,18671.0,Abcb1a,10090,Mus musculus (house mouse),ABCB1A protein affects the uptake of paclitaxel,,,PMID:10562306,https://www.ncbi.nlm.nih.gov/pubmed/10562306,10562306,,
203,1316234,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,18669,ABCB1B,https://ctdbase.org/detail.go?type=gene&acc=18669,,,18669.0,Abcb1b,10090,Mus musculus (house mouse),ABCB1B protein affects the uptake of paclitaxel,,,PMID:10562306,https://www.ncbi.nlm.nih.gov/pubmed/10562306,10562306,,
204,1316235,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,9606,Homo sapiens (human),ABCB4 protein results in decreased susceptibility to paclitaxel,,,PMID:17697605,https://www.ncbi.nlm.nih.gov/pubmed/17697605,17697605,,
205,1316236,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,10058,ABCB6,https://ctdbase.org/detail.go?type=gene&acc=10058,,,10058.0,ABCB6,9606,Homo sapiens (human),Paclitaxel results in decreased expression of ABCB6 mRNA,,,PMID:20737486,https://www.ncbi.nlm.nih.gov/pubmed/20737486,20737486,,
206,1316237,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),ABCC1 results in decreased susceptibility to paclitaxel,,,PMID:15548710,https://www.ncbi.nlm.nih.gov/pubmed/15548710,15548710,,
207,1316238,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),HIF1A protein affects the reaction [[paclitaxel co-treated with IL6 protein] results in increased expression of ABCC1 protein]|[paclitaxel co-treated with IL6 protein] results in increased expression of ABCC1 protein,,,PMID:29341321,https://www.ncbi.nlm.nih.gov/pubmed/29341321,29341321,,
208,1316239,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,89845,ABCC10,https://ctdbase.org/detail.go?type=gene&acc=89845,,,89845.0,ABCC10,9606,Homo sapiens (human),Imatinib mesylate inhibits the reaction [ABCC10 protein results in decreased susceptibility to paclitaxel]|nilotinib inhibits the reaction [ABCC10 protein results in decreased abundance of and results in increased secretion of paclitaxel]|abcc10 protein results in decreased susceptibility to paclitaxel|nilotinib inhibits the reaction [ABCC10 protein results in decreased susceptibility to paclitaxel]|abcc10 protein results in decreased abundance of and results in increased secretion of paclitaxel|imatinib mesylate inhibits the reaction [ABCC10 protein results in decreased abundance of and results in increased secretion of paclitaxel],,,PMID:19841739,https://www.ncbi.nlm.nih.gov/pubmed/19841739,19841739,,
209,1317679,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Hesperidin inhibits the reaction [paclitaxel results in increased expression of BAX mrna]|paclitaxel results in increased expression of BAX mrna|hesperidin inhibits the reaction [paclitaxel results in increased expression of BAX protein]|paclitaxel results in increased expression of BAX protein,,,PMID:35921949|PMID:36966900,https://www.ncbi.nlm.nih.gov/pubmed/35921949|https://www.ncbi.nlm.nih.gov/pubmed/36966900,35921949|36966900,,
210,1317680,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),BCL2L1 protein inhibits the reaction [paclitaxel results in increased expression of BAX protein],,,PMID:10516758,https://www.ncbi.nlm.nih.gov/pubmed/10516758,10516758,,
211,1317681,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606,Homo sapiens (human),Paclitaxel results in increased expression of BBC3 protein|paclitaxel results in increased expression of BBC3 mrna|bbc3 protein results in increased susceptibility to paclitaxel,,,PMID:16481741,https://www.ncbi.nlm.nih.gov/pubmed/16481741,16481741,,
212,1317682,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,585,BBS4,https://ctdbase.org/detail.go?type=gene&acc=585,,,585.0,BBS4,9606,Homo sapiens (human),BBS4 mRNA affects the susceptibility to [paclitaxel co-treated with fluorouracil co-treated with doxorubicin co-treated with cyclophosphamide],,,PMID:16896004,https://www.ncbi.nlm.nih.gov/pubmed/16896004,16896004,,
213,1317683,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),"3,3'-diindolylmethane promotes the reaction [paclitaxel results in decreased expression of BCL2 protein]",,,PMID:16580691,https://www.ncbi.nlm.nih.gov/pubmed/16580691,16580691,,
214,1317684,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),MAPK8 protein affects the reaction [paclitaxel results in increased phosphorylation of BCL2 protein]|aspartyl-glutamyl-valyl-aspartal inhibits the reaction [paclitaxel results in increased phosphorylation of BCL2 protein]|map3k1 protein affects the reaction [paclitaxel results in increased phosphorylation of BCL2 protein],,,PMID:11160861,https://www.ncbi.nlm.nih.gov/pubmed/11160861,11160861,,
215,1317685,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 mRNA results in decreased susceptibility to paclitaxel,,,PMID:16322897,https://www.ncbi.nlm.nih.gov/pubmed/16322897,16322897,,
216,1317686,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 protein affects the susceptibility to paclitaxel|bcl2 protein mutant form results in increased susceptibility to paclitaxel,,,PMID:20610805,https://www.ncbi.nlm.nih.gov/pubmed/20610805,20610805,,
217,1317687,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),BCL2 protein results in decreased susceptibility to paclitaxel,,,PMID:16275990,https://www.ncbi.nlm.nih.gov/pubmed/16275990,16275990,,
218,1318018,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Quercetin inhibits the reaction [paclitaxel results in increased phosphorylation of BCL2 protein],,,PMID:11597122,https://www.ncbi.nlm.nih.gov/pubmed/11597122,11597122,,
219,1318019,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),Resveratrol inhibits the reaction [paclitaxel results in increased phosphorylation of BCL2 protein],,,PMID:12510025,https://www.ncbi.nlm.nih.gov/pubmed/12510025,12510025,,
220,1318020,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[tretinoin co-treated with paclitaxel] results in decreased expression of BCL2 protein,,,PMID:17701358,https://www.ncbi.nlm.nih.gov/pubmed/17701358,17701358,,
221,1318021,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),[tretinoin co-treated with paclitaxel] results in increased phosphorylation of BCL2 protein,,,PMID:18098270,https://www.ncbi.nlm.nih.gov/pubmed/18098270,18098270,,
222,1318022,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090,Mus musculus (house mouse),[glabridin co-treated with paclitaxel] results in decreased expression of BCL2 protein,,,PMID:37419298,https://www.ncbi.nlm.nih.gov/pubmed/37419298,37419298,,
223,1318023,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090,Mus musculus (house mouse),Paclitaxel results in decreased expression of BCL2 mRNA,,,PMID:35584731,https://www.ncbi.nlm.nih.gov/pubmed/35584731,35584731,,
224,1318024,36314,Comparative Toxicogenomics Database (CTD),Paclitaxel,D017239,Paclitaxel,https://ctdbase.org/detail.go?type=chem&acc=D017239,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090,Mus musculus (house mouse),Rottlerin promotes the reaction [paclitaxel results in decreased expression of BCL2 protein]|paclitaxel results in decreased expression of BCL2 protein,,,PMID:35995259,https://www.ncbi.nlm.nih.gov/pubmed/35995259,35995259,,
225,1313655,36462,Drug Gene Interaction database (DGIdb),Etoposide,,ETOPOSIDE,https://www.dgidb.org/drugs/rxcui:4179,,IGF2,https://www.dgidb.org/genes/hgnc:5466,,,3481.0,IGF2,9606,Homo sapiens (human),,,,,,,,
226,1313656,36462,Drug Gene Interaction database (DGIdb),Etoposide,,ETOPOSIDE,https://www.dgidb.org/drugs/rxcui:4179,,MYCN,https://www.dgidb.org/genes/hgnc:7559,,,4613.0,MYCN,9606,Homo sapiens (human),,,,,,,,
227,1313657,36462,Drug Gene Interaction database (DGIdb),Etoposide,,ETOPOSIDE,https://www.dgidb.org/drugs/rxcui:4179,,TOP2A,https://www.dgidb.org/genes/hgnc:11989,,,7153.0,TOP2A,9606,Homo sapiens (human),,,,,,,,
228,1313658,36462,Drug Gene Interaction database (DGIdb),Etoposide,,ETOPOSIDE,https://www.dgidb.org/drugs/rxcui:4179,,TOP2A,https://www.dgidb.org/genes/hgnc:11989,,,7153.0,TOP2A,9606,Homo sapiens (human),,,,,,,,
229,1316662,36573,Comparative Toxicogenomics Database (CTD),Acesulfame,C006362,acetosulfame,https://ctdbase.org/detail.go?type=chem&acc=C006362,83756,TAS1R3,https://ctdbase.org/detail.go?type=gene&acc=83756,,,83756.0,TAS1R3,10090,Mus musculus (house mouse),TAS1R3 protein affects the susceptibility to acetosulfame|trpv1 protein affects the reaction [TAS1R3 protein affects the susceptibility to acetosulfame],,,PMID:18804451,https://www.ncbi.nlm.nih.gov/pubmed/18804451,18804451,,
230,1316663,36573,Comparative Toxicogenomics Database (CTD),Acesulfame,C006362,acetosulfame,https://ctdbase.org/detail.go?type=chem&acc=C006362,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,9606,Homo sapiens (human),Acetosulfame results in increased activity of TRPV1 protein,,,PMID:17567713|PMID:18804451,https://www.ncbi.nlm.nih.gov/pubmed/17567713|https://www.ncbi.nlm.nih.gov/pubmed/18804451,17567713|18804451,,
231,1316664,36573,Comparative Toxicogenomics Database (CTD),Acesulfame,C006362,acetosulfame,https://ctdbase.org/detail.go?type=chem&acc=C006362,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,10090,Mus musculus (house mouse),TRPV1 protein affects the reaction [TAS1R3 protein affects the susceptibility to acetosulfame],,,PMID:18804451,https://www.ncbi.nlm.nih.gov/pubmed/18804451,18804451,,
232,1314358,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,35561,FMO-2,https://ctdbase.org/detail.go?type=gene&acc=35561,,,35561.0,Fmo-2,29159,Crassostrea gigas (Pacific oyster),[atrazine co-treated with diuron co-treated with isoproturon] results in increased expression of FMO-2 mRNA,,,PMID:15245914,https://www.ncbi.nlm.nih.gov/pubmed/15245914,15245914,,
233,1314950,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,80213,TM2D3,https://ctdbase.org/detail.go?type=gene&acc=80213,,,80213.0,TM2D3,8260,Platichthys flesus (European flounder),[atrazine co-treated with diuron co-treated with isoproturon] results in increased expression of TM2D3 mRNA,,,PMID:16532367,https://www.ncbi.nlm.nih.gov/pubmed/16532367,16532367,,
234,1314951,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,7140,TNNT3,https://ctdbase.org/detail.go?type=gene&acc=7140,,,7140.0,TNNT3,8260,Platichthys flesus (European flounder),[atrazine co-treated with diuron co-treated with isoproturon] results in decreased expression of TNNT3 mRNA,,,PMID:16532367,https://www.ncbi.nlm.nih.gov/pubmed/16532367,16532367,,
235,1314952,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,23321,TRIM2,https://ctdbase.org/detail.go?type=gene&acc=23321,,,23321.0,TRIM2,29159,Crassostrea gigas (Pacific oyster),[atrazine co-treated with diuron co-treated with isoproturon] results in decreased expression of TRIM2 mRNA,,,PMID:15654877,https://www.ncbi.nlm.nih.gov/pubmed/15654877,15654877,,
236,1314953,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,7846,TUBA1A,https://ctdbase.org/detail.go?type=gene&acc=7846,,,7846.0,TUBA1A,29159,Crassostrea gigas (Pacific oyster),[atrazine co-treated with diuron co-treated with isoproturon] results in increased expression of TUBA1A mRNA,,,PMID:15654877,https://www.ncbi.nlm.nih.gov/pubmed/15654877,15654877,,
237,1314954,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,203068,TUBB,https://ctdbase.org/detail.go?type=gene&acc=203068,,,203068.0,TUBB,29159,Crassostrea gigas (Pacific oyster),[atrazine co-treated with diuron co-treated with isoproturon] results in increased expression of TUBB mRNA,,,PMID:15654877,https://www.ncbi.nlm.nih.gov/pubmed/15654877,15654877,,
238,1314955,36679,Comparative Toxicogenomics Database (CTD),Isoproturon,C028904,isoproturon,https://ctdbase.org/detail.go?type=chem&acc=C028904,7534,YWHAZ,https://ctdbase.org/detail.go?type=gene&acc=7534,,,7534.0,YWHAZ,29159,Crassostrea gigas (Pacific oyster),Isoproturon results in increased expression of YWHAZ protein,,,PMID:26313537,https://www.ncbi.nlm.nih.gov/pubmed/26313537,26313537,,
239,1314956,36708,Drug Gene Interaction database (DGIdb),Propafenone Hydrochloride,,PROPAFENONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203135,,SCN9A,https://www.dgidb.org/genes/hgnc:10597,,,6335.0,SCN9A,9606,Homo sapiens (human),Blocker,,,,,,,
240,1314957,36708,Drug Gene Interaction database (DGIdb),Propafenone Hydrochloride,,PROPAFENONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203135,,SCN4A,https://www.dgidb.org/genes/hgnc:10591,,,6329.0,SCN4A,9606,Homo sapiens (human),Blocker,,,,,,,
241,1316665,36708,ChEMBL,Propafenone Hydrochloride,CHEMBL1201063,PROPAFENONE HYDROCHLORIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201063/,CHEMBL213,Beta-1 adrenergic receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL213/,P08588,Beta-1 adrenergic receptor,153.0,ADRB1,9606,Homo sapiens (human),Beta-1 adrenergic receptor antagonist,,,,,,,
242,1316666,36708,Drug Gene Interaction database (DGIdb),Propafenone Hydrochloride,,PROPAFENONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203135,,SCN2A,https://www.dgidb.org/genes/hgnc:10588,,,6326.0,SCN2A,9606,Homo sapiens (human),Blocker,,,,,,,
243,1316667,36708,Drug Gene Interaction database (DGIdb),Propafenone Hydrochloride,,PROPAFENONE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203135,,SCN5A,https://www.dgidb.org/genes/hgnc:10593,,,6331.0,SCN5A,9606,Homo sapiens (human),Blocker,,,,,,,
244,1313320,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,29899,GPSM2,https://ctdbase.org/detail.go?type=gene&acc=29899,,,29899.0,GPSM2,9606,Homo sapiens (human),Methoxyacetic acid promotes the reaction [promegestone results in increased expression of GPSM2 mrna]|promegestone results in increased expression of GPSM2 mRNA,,,PMID:15103026,https://www.ncbi.nlm.nih.gov/pubmed/15103026,15103026,,
245,1313321,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6596,HLTF,https://ctdbase.org/detail.go?type=gene&acc=6596,,,6596.0,HLTF,9986,Oryctolagus cuniculus (rabbit),"2-(benzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylonitrile inhibits the reaction [[promegestone co-treated with PRL protein] results in increased expression of HLTF mrna]|[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|[1,2,3,4,5,6-hexabromocyclohexane co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|[promegestone co-treated with PRL protein] results in increased expression of HLTF mrna|[2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|[tg101209 co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|promegestone results in increased phosphorylation of HLTF protein|[2-(benzylaminocarbonyl)-3-(3,4-dihydroxystyryl)acrylonitrile co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|[staurosporine co-treated with PRL protein] inhibits the reaction [promegestone results in increased phosphorylation of HLTF protein]|[jak2 protein co-treated with PRL protein] promotes the reaction [promegestone results in increased phosphorylation of HLTF protein]",,,PMID:20562009,https://www.ncbi.nlm.nih.gov/pubmed/20562009,20562009,,
246,1313322,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,3294,HSD17B2,https://ctdbase.org/detail.go?type=gene&acc=3294,,,3294.0,HSD17B2,9606,Homo sapiens (human),Mithramycin A inhibits the reaction [promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]]|mithramycin A inhibits the reaction [promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]]|promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]|promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter],,,PMID:16807381,https://www.ncbi.nlm.nih.gov/pubmed/16807381,16807381,,
247,1313818,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,5931,RBBP7,https://ctdbase.org/detail.go?type=gene&acc=5931,,,5931.0,RBBP7,9606,Homo sapiens (human),Methoxyacetic acid promotes the reaction [promegestone results in increased expression of RBBP7 mrna]|promegestone results in increased expression of RBBP7 mRNA,,,PMID:15103026,https://www.ncbi.nlm.nih.gov/pubmed/15103026,15103026,,
248,1313819,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6286,S100P,https://ctdbase.org/detail.go?type=gene&acc=6286,,,6286.0,S100P,9606,Homo sapiens (human),Promegestone results in increased expression of S100P mrna|methoxyacetic acid promotes the reaction [promegestone results in increased expression of S100P mrna],,,PMID:15103026,https://www.ncbi.nlm.nih.gov/pubmed/15103026,15103026,,
249,1313820,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6595,SMARCA2,https://ctdbase.org/detail.go?type=gene&acc=6595,,,6595.0,SMARCA2,9606,Homo sapiens (human),SMARCA2 protein affects the reaction [promegestone results in increased expression of FOS mrna]|smarca2 protein affects the reaction [promegestone results in increased expression of MYC mrna],,,PMID:19609353,https://www.ncbi.nlm.nih.gov/pubmed/19609353,19609353,,
250,1313821,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6597,SMARCA4,https://ctdbase.org/detail.go?type=gene&acc=6597,,,6597.0,SMARCA4,9606,Homo sapiens (human),SMARCA4 protein affects the reaction [promegestone results in increased expression of FOS mrna]|smarca4 protein affects the reaction [promegestone results in increased expression of MYC mrna],,,PMID:19609353,https://www.ncbi.nlm.nih.gov/pubmed/19609353,19609353,,
251,1313822,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6605,SMARCE1,https://ctdbase.org/detail.go?type=gene&acc=6605,,,6605.0,SMARCE1,9606,Homo sapiens (human),Promegestone promotes the reaction [SMARCE1 protein binds to PGR protein],,,PMID:19609353,https://www.ncbi.nlm.nih.gov/pubmed/19609353,19609353,,
252,1313823,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6667,SP1,https://ctdbase.org/detail.go?type=gene&acc=6667,,,6667.0,SP1,9606,Homo sapiens (human),Promegestone results in increased expression of SP1 mrna|mithramycin A inhibits the reaction [promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]]|promegestone results in increased expression of SP1 protein|promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter],,,PMID:16807381,https://www.ncbi.nlm.nih.gov/pubmed/16807381,16807381,,
253,1313824,36709,Comparative Toxicogenomics Database (CTD),Promegestone,D011397,Promegestone,https://ctdbase.org/detail.go?type=chem&acc=D011397,6670,SP3,https://ctdbase.org/detail.go?type=gene&acc=6670,,,6670.0,SP3,9606,Homo sapiens (human),Mithramycin A inhibits the reaction [promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]]|promegestone promotes the reaction [SP3 protein binds to HSD17B2 promoter]|promegestone results in increased expression of SP3 protein|promegestone results in increased expression of SP3 mRNA,,,PMID:16807381,https://www.ncbi.nlm.nih.gov/pubmed/16807381,16807381,,
254,1312635,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,6547,SLC8A3,https://ctdbase.org/detail.go?type=gene&acc=6547,,,6547.0,SLC8A3,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SLC8A3 mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
255,1312990,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,55512,SMPD3,https://ctdbase.org/detail.go?type=gene&acc=55512,,,55512.0,SMPD3,10090,Mus musculus (house mouse),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SMPD3 mRNA",,,PMID:20005886,https://www.ncbi.nlm.nih.gov/pubmed/20005886,20005886,,
256,1312991,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,23676,SMPX,https://ctdbase.org/detail.go?type=gene&acc=23676,,,23676.0,SMPX,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMPX mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
257,1312992,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,150572,SMYD1,https://ctdbase.org/detail.go?type=gene&acc=150572,,,150572.0,SMYD1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
258,1312993,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,23557,SNAPIN,https://ctdbase.org/detail.go?type=gene&acc=23557,,,23557.0,SNAPIN,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SNAPIN mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
259,1314350,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,29906,ST8SIA5,https://ctdbase.org/detail.go?type=gene&acc=29906,,,29906.0,ST8SIA5,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ST8SIA5 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
260,1314351,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,55576,STAB2,https://ctdbase.org/detail.go?type=gene&acc=55576,,,55576.0,STAB2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STAB2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
261,1314352,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,567168,STAG2A,https://ctdbase.org/detail.go?type=gene&acc=567168,,,567168.0,stag2a,7955,Danio rerio (zebrafish),"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of STAG2A mRNA",,,PMID:31621872,https://www.ncbi.nlm.nih.gov/pubmed/31621872,31621872,,
262,1314353,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9031,Gallus gallus (chicken),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of STAR mRNA",,,PMID:27832956,https://www.ncbi.nlm.nih.gov/pubmed/27832956,27832956,,
263,1314354,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,10090,Mus musculus (house mouse),"[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased phosphorylation of STAT3 protein|[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased phosphorylation of STAT3 protein",,,PMID:24978599,https://www.ncbi.nlm.nih.gov/pubmed/24978599,24978599,,
264,1314355,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,6776,STAT5A,https://ctdbase.org/detail.go?type=gene&acc=6776,,,6776.0,STAT5A,29158,Mytilus galloprovincialis (Mediterranean mussel),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased phosphorylation of STAT5A protein",,,PMID:12711418,https://www.ncbi.nlm.nih.gov/pubmed/12711418,12711418,,
265,1314356,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,6491,STIL,https://ctdbase.org/detail.go?type=gene&acc=6491,,,6491.0,STIL,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
266,1314357,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,140901,STK35,https://ctdbase.org/detail.go?type=gene&acc=140901,,,140901.0,STK35,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of STK35 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
267,1315553,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,233670,OR6B9,https://ctdbase.org/detail.go?type=gene&acc=233670,,,233670.0,Or6b9,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6B9 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
268,1315554,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,258862,OR6C201,https://ctdbase.org/detail.go?type=gene&acc=258862,,,258862.0,Or6c201,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6C201 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
269,1315555,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,391112,OR6Y1,https://ctdbase.org/detail.go?type=gene&acc=391112,,,391112.0,OR6Y1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of OR6Y1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
270,1315900,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl results in increased activity of PARP1 protein",,,PMID:16884709,https://www.ncbi.nlm.nih.gov/pubmed/16884709,16884709,,
271,1317495,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,18730,PIRA7,https://ctdbase.org/detail.go?type=gene&acc=18730,,,18730.0,Pira7,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIRA7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
272,1317496,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,9600,PITPNM1,https://ctdbase.org/detail.go?type=gene&acc=9600,,,9600.0,PITPNM1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PITPNM1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
273,1317497,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,494513,PJVK,https://ctdbase.org/detail.go?type=gene&acc=494513,,,494513.0,PJVK,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PJVK mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
274,1317498,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,5570,PKIB,https://ctdbase.org/detail.go?type=gene&acc=5570,,,5570.0,PKIB,9606,Homo sapiens (human),"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of PKIB mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
275,1317499,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,5315,PKM,https://ctdbase.org/detail.go?type=gene&acc=5315,,,5315.0,PKM,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PKM protein]|2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of and affects the localization of and results in increased activity of PKM protein|2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PKM mrna|2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PKM protein",,,PMID:30821169,https://www.ncbi.nlm.nih.gov/pubmed/30821169,30821169,,
276,1317500,37034,Comparative Toxicogenomics Database (CTD),"2,2',4,4',5,5'-Hexachlorobiphenyl",C014024,"2,4,5,2',4',5'-hexachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C014024,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579.0,PLA2G12A,10090,Mus musculus (house mouse),"2,4,5,2',4',5'-hexachlorobiphenyl affects the reaction [NR1I2 protein affects the expression of PLA2G12A mrna]",,,PMID:32352317,https://www.ncbi.nlm.nih.gov/pubmed/32352317,32352317,,
277,1314158,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,85459,CEP295,https://ctdbase.org/detail.go?type=gene&acc=85459,,,85459.0,CEP295,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CEP295 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
278,1314159,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,55165,CEP55,https://ctdbase.org/detail.go?type=gene&acc=55165,,,55165.0,CEP55,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
279,1314160,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,204219,CERS3,https://ctdbase.org/detail.go?type=gene&acc=204219,,,204219.0,CERS3,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CERS3 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
280,1314161,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,13897,CES1E,https://ctdbase.org/detail.go?type=gene&acc=13897,,,13897.0,Ces1e,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CES1E mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
281,1314162,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,348807,CFAP100,https://ctdbase.org/detail.go?type=gene&acc=348807,,,348807.0,CFAP100,10116,Rattus norvegicus (Norway rat),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of CFAP100 mRNA",,,PMID:23829299,https://www.ncbi.nlm.nih.gov/pubmed/23829299,23829299,,
282,1314163,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,55997,CFC1,https://ctdbase.org/detail.go?type=gene&acc=55997,,,55997.0,CFC1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CFC1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
283,1315373,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,51226,COPZ2,https://ctdbase.org/detail.go?type=gene&acc=51226,,,51226.0,COPZ2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of COPZ2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
284,1315374,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,7464,CORO2A,https://ctdbase.org/detail.go?type=gene&acc=7464,,,7464.0,CORO2A,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CORO2A mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
285,1317334,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,27121,DKK4,https://ctdbase.org/detail.go?type=gene&acc=27121,,,27121.0,DKK4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DKK4 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
286,1317335,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,8847,DLEU2,https://ctdbase.org/detail.go?type=gene&acc=8847,,,8847.0,DLEU2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DLEU2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
287,1317336,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,220107,DLEU7,https://ctdbase.org/detail.go?type=gene&acc=220107,,,220107.0,DLEU7,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLEU7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
288,1317337,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,1740,DLG2,https://ctdbase.org/detail.go?type=gene&acc=1740,,,1740.0,DLG2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DLG2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
289,1317338,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180 co-treated with APP protein modified form] results in decreased expression of DLG4 protein",,,PMID:26480858,https://www.ncbi.nlm.nih.gov/pubmed/26480858,26480858,,
290,1317339,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,9229,DLGAP1,https://ctdbase.org/detail.go?type=gene&acc=9229,,,9229.0,DLGAP1,9606,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of DLGAP1 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
291,1318682,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,90459,ERI1,https://ctdbase.org/detail.go?type=gene&acc=90459,,,90459.0,ERI1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ERI1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
292,1318683,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,112479,ERI2,https://ctdbase.org/detail.go?type=gene&acc=112479,,,112479.0,ERI2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ERI2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
293,1318684,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,114799,ESCO1,https://ctdbase.org/detail.go?type=gene&acc=114799,,,114799.0,ESCO1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ESCO1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
294,1318685,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,2150,F2RL1,https://ctdbase.org/detail.go?type=gene&acc=2150,,,2150.0,F2RL1,9606,Homo sapiens (human),"2,5,2',5'-tetrachlorobiphenyl results in increased expression of F2RL1 mrna|2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of F2RL1 mRNA",,,PMID:36804509,https://www.ncbi.nlm.nih.gov/pubmed/36804509,36804509,,
295,1318686,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,646480,FABP9,https://ctdbase.org/detail.go?type=gene&acc=646480,,,646480.0,FABP9,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FABP9 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
296,1318687,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,23017,FAIM2,https://ctdbase.org/detail.go?type=gene&acc=23017,,,23017.0,FAIM2,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAIM2 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
297,1318688,37248,Comparative Toxicogenomics Database (CTD),"2,2',5,5'-Tetrachlorobiphenyl",C009407,"2,5,2',5'-tetrachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009407,220965,FAM13C,https://ctdbase.org/detail.go?type=gene&acc=220965,,,220965.0,FAM13C,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of FAM13C mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
298,1316793,37336,Comparative Toxicogenomics Database (CTD),"N,N'-Bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",C037740,"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",https://ctdbase.org/detail.go?type=chem&acc=C037740,1147,CHUK,https://ctdbase.org/detail.go?type=gene&acc=1147,,,1147.0,CHUK,10116,Rattus norvegicus (Norway rat),"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid inhibits the reaction [ferrous sulfate results in increased activity of [CHUK protein binds to IKBKB protein]]|n,n'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid inhibits the reaction [iron results in increased activity of [CHUK protein binds to IKBKB protein]]",,,PMID:17172471,https://www.ncbi.nlm.nih.gov/pubmed/17172471,17172471,,
299,1316794,37336,Comparative Toxicogenomics Database (CTD),"N,N'-Bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",C037740,"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",https://ctdbase.org/detail.go?type=chem&acc=C037740,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10116,Rattus norvegicus (Norway rat),"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid inhibits the reaction [ferrous sulfate results in increased activity of [CHUK protein binds to IKBKB protein]]|n,n'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid inhibits the reaction [iron results in increased activity of [CHUK protein binds to IKBKB protein]]",,,PMID:17172471,https://www.ncbi.nlm.nih.gov/pubmed/17172471,17172471,,
300,1316795,37336,Comparative Toxicogenomics Database (CTD),"N,N'-Bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",C037740,"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid",https://ctdbase.org/detail.go?type=chem&acc=C037740,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,9606,Homo sapiens (human),"N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA mRNA alternative form]",,,PMID:19857570,https://www.ncbi.nlm.nih.gov/pubmed/19857570,19857570,,
301,1316796,37393,DrugBank,Halofantrine,DB01218,Halofantrine,https://www.drugbank.ca/drugs/DB01218,BE0000090,Potassium voltage-gated channel subfamily H member 2,https://www.drugbank.ca/bio_entities/BE0000090,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606,Homo sapiens (human),Inhibitor,,,PMID:10952689|PMID:12176129,https://www.ncbi.nlm.nih.gov/pubmed/10952689|https://www.ncbi.nlm.nih.gov/pubmed/12176129,10952689|12176129,,
302,1316797,37393,DrugBank,Halofantrine,DB01218,Halofantrine,https://www.drugbank.ca/drugs/DB01218,BE0001694,Plasmepsin-2,https://www.drugbank.ca/bio_entities/BE0001694,P46925,Plasmepsin-2,,,137071,Plasmodium falciparum HB3,Inhibitor,,,PMID:19472268,https://www.ncbi.nlm.nih.gov/pubmed/19472268,19472268,,
303,1317857,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,128434,VSTM2L,https://ctdbase.org/detail.go?type=gene&acc=128434,,,128434.0,VSTM2L,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
304,1317858,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,79679,VTCN1,https://ctdbase.org/detail.go?type=gene&acc=79679,,,79679.0,VTCN1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VTCN1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
305,1317859,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,402117,VWC2L,https://ctdbase.org/detail.go?type=gene&acc=402117,,,402117.0,VWC2L,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VWC2L mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
306,1317860,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,23039,XPO7,https://ctdbase.org/detail.go?type=gene&acc=23039,,,23039.0,XPO7,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of XPO7 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
307,1317861,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,29799,YPEL1,https://ctdbase.org/detail.go?type=gene&acc=29799,,,29799.0,YPEL1,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of YPEL1 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
308,1317862,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,65986,ZBTB10,https://ctdbase.org/detail.go?type=gene&acc=65986,,,65986.0,ZBTB10,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB10 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
309,1317863,37807,Comparative Toxicogenomics Database (CTD),"2,2',4,5,5'-Pentachlorobiphenyl",C009828,"2,4,5,2',5'-pentachlorobiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C009828,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,10090,Mus musculus (house mouse),"[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZBTB20 mRNA",,,PMID:25510870,https://www.ncbi.nlm.nih.gov/pubmed/25510870,25510870,,
310,1316456,38779,Comparative Toxicogenomics Database (CTD),Profenofos,C024273,profenofos,https://ctdbase.org/detail.go?type=chem&acc=C024273,64231,MS4A6A,https://ctdbase.org/detail.go?type=gene&acc=64231,,,64231.0,MS4A6A,10116,Rattus norvegicus (Norway rat),Profenofos results in increased expression of MS4A6A mRNA,,,PMID:17569032,https://www.ncbi.nlm.nih.gov/pubmed/17569032,17569032,,
311,1317331,39042,Comparative Toxicogenomics Database (CTD),Bezafibrate,D001629,Bezafibrate,https://ctdbase.org/detail.go?type=chem&acc=D001629,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,10116,Rattus norvegicus (Norway rat),Bezafibrate results in increased activity of SCD protein,,,PMID:7606338,https://www.ncbi.nlm.nih.gov/pubmed/7606338,7606338,,
312,1317332,39042,Comparative Toxicogenomics Database (CTD),Bezafibrate,D001629,Bezafibrate,https://ctdbase.org/detail.go?type=chem&acc=D001629,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,9606,Homo sapiens (human),Bezafibrate results in increased expression of SCD1 mrna|bezafibrate results in increased activity of SCD1 protein,,,PMID:11172741,https://www.ncbi.nlm.nih.gov/pubmed/11172741,11172741,,
313,1317333,39042,Comparative Toxicogenomics Database (CTD),Bezafibrate,D001629,Bezafibrate,https://ctdbase.org/detail.go?type=chem&acc=D001629,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,9606,Homo sapiens (human),[oleic acid co-treated with bezafibrate] results in increased expression of SCD1 mRNA,,,PMID:24534255,https://www.ncbi.nlm.nih.gov/pubmed/24534255,24534255,,
314,1318335,39186,Toxin and Toxin Target Database (T3DB),Diltiazem,T3D2758,Diltiazem,http://www.t3db.ca/toxins/T3D2758,BE0001067,ATP-binding cassette sub-family G member 2,http://www.t3db.ca/biodb/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606,Homo sapiens (human),,,,PMID:18678495,https://www.ncbi.nlm.nih.gov/pubmed/18678495,18678495,,
315,1318336,39186,Toxin and Toxin Target Database (T3DB),Diltiazem,T3D2758,Diltiazem,http://www.t3db.ca/toxins/T3D2758,BE0001032,Multidrug resistance protein 1,http://www.t3db.ca/biodb/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),,,,PMID:17890094,https://www.ncbi.nlm.nih.gov/pubmed/17890094,17890094,,
316,1318337,39186,Toxin and Toxin Target Database (T3DB),Diltiazem,T3D2758,Diltiazem,http://www.t3db.ca/toxins/T3D2758,BE0003648,Solute carrier family 22 member 1,http://www.t3db.ca/biodb/bio_entities/BE0003648,O15245,Solute carrier family 22 member 1 ,6580.0,SLC22A1,9606,Homo sapiens (human),,,,PMID:18788725,https://www.ncbi.nlm.nih.gov/pubmed/18788725,18788725,,
317,1318338,39214,Drug Gene Interaction database (DGIdb),Nimustine,,NIMUSTINE,https://www.dgidb.org/drugs/ncit:C693,,CDKN1A,https://www.dgidb.org/genes/hgnc:1784,,,1026.0,CDKN1A,9606,Homo sapiens (human),,,,,,,,
318,1318339,39214,Drug Gene Interaction database (DGIdb),Nimustine,,NIMUSTINE,https://www.dgidb.org/drugs/ncit:C693,,IL1B,https://www.dgidb.org/genes/hgnc:5992,,,3553.0,IL1B,9606,Homo sapiens (human),,,,,,,,
319,1318679,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,11274,USP18,https://ctdbase.org/detail.go?type=gene&acc=11274,,,11274.0,USP18,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of USP18 mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
320,1318680,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,389856,USP27X,https://ctdbase.org/detail.go?type=gene&acc=389856,,,389856.0,USP27X,10116,Rattus norvegicus (Norway rat),1-methyl-4-phenylpyridinium results in increased expression of USP27X mRNA,,,PMID:28801915,https://www.ncbi.nlm.nih.gov/pubmed/28801915,28801915,,
321,1318681,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,10713,USP39,https://ctdbase.org/detail.go?type=gene&acc=10713,,,10713.0,USP39,10090,Mus musculus (house mouse),1-methyl-4-phenylpyridinium results in increased expression of USP39 protein,,,PMID:26558463,https://www.ncbi.nlm.nih.gov/pubmed/26558463,26558463,,
322,1307057,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,30819,KCNIP2,https://ctdbase.org/detail.go?type=gene&acc=30819,,,30819.0,KCNIP2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of KCNIP2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
323,1307058,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,30818,KCNIP3,https://ctdbase.org/detail.go?type=gene&acc=30818,,,30818.0,KCNIP3,9823,Sus scrofa (pig),Deoxynivalenol affects the expression of KCNIP3 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
324,1307059,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,3767,KCNJ11,https://ctdbase.org/detail.go?type=gene&acc=3767,,,3767.0,KCNJ11,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of KCNJ11 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
325,1308226,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,130940,CCDC148,https://ctdbase.org/detail.go?type=gene&acc=130940,,,130940.0,CCDC148,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CCDC148 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
326,1308227,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,347475,CCDC160,https://ctdbase.org/detail.go?type=gene&acc=347475,,,347475.0,CCDC160,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CCDC160 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
327,1308228,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,221262,CCDC162P,https://ctdbase.org/detail.go?type=gene&acc=221262,,,221262.0,CCDC162P,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CCDC162P mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
328,1308229,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,100130274,CCDC166,https://ctdbase.org/detail.go?type=gene&acc=100130274,,,100130274.0,CCDC166,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CCDC166 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
329,1308230,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,80129,CCDC170,https://ctdbase.org/detail.go?type=gene&acc=80129,,,80129.0,CCDC170,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CCDC170 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
330,1308231,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,51244,CCDC174,https://ctdbase.org/detail.go?type=gene&acc=51244,,,51244.0,CCDC174,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CCDC174 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
331,1312790,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,90993,CREB3L1,https://ctdbase.org/detail.go?type=gene&acc=90993,,,90993.0,CREB3L1,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CREB3L1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
332,1312791,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,64764,CREB3L2,https://ctdbase.org/detail.go?type=gene&acc=64764,,,64764.0,CREB3L2,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CREB3L2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
333,1313138,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1408,CRY2,https://ctdbase.org/detail.go?type=gene&acc=1408,,,1408.0,CRY2,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CRY2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
334,1313139,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1410,CRYAB,https://ctdbase.org/detail.go?type=gene&acc=1410,,,1410.0,CRYAB,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CRYAB mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
335,1313140,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,55057,CRYBG2,https://ctdbase.org/detail.go?type=gene&acc=55057,,,55057.0,CRYBG2,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CRYBG2 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
336,1313141,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,131544,CRYBG3,https://ctdbase.org/detail.go?type=gene&acc=131544,,,131544.0,CRYBG3,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of CRYBG3 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
337,1314735,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),Deoxynivalenol results in decreased expression of CYP1B1 mRNA,,,PMID:20702593,https://www.ncbi.nlm.nih.gov/pubmed/20702593,20702593,,
338,1314736,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1589,CYP21A2,https://ctdbase.org/detail.go?type=gene&acc=1589,,,1589.0,CYP21A2,9606,Homo sapiens (human),Deoxynivalenol results in increased expression of CYP21A2 mRNA,,,PMID:22982764,https://www.ncbi.nlm.nih.gov/pubmed/22982764,22982764,,
339,1314737,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1592,CYP26A1,https://ctdbase.org/detail.go?type=gene&acc=1592,,,1592.0,CYP26A1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP26A1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
340,1314738,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP27A1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
341,1314739,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,403149,CYP2A19,https://ctdbase.org/detail.go?type=gene&acc=403149,,,403149.0,CYP2A19,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP2A19 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
342,1314740,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,403107,CYP2C33,https://ctdbase.org/detail.go?type=gene&acc=403107,,,403107.0,CYP2C33,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP2C33 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
343,1314741,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,403111,CYP2C42,https://ctdbase.org/detail.go?type=gene&acc=403111,,,403111.0,CYP2C42,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP2C42 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
344,1314742,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,113612,CYP2U1,https://ctdbase.org/detail.go?type=gene&acc=113612,,,113612.0,CYP2U1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP2U1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
345,1314743,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,51302,CYP39A1,https://ctdbase.org/detail.go?type=gene&acc=51302,,,51302.0,CYP39A1,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of CYP39A1 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
346,1316791,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10072,DPP3,https://ctdbase.org/detail.go?type=gene&acc=10072,,,10072.0,DPP3,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of DPP3 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
347,1316792,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,1803,DPP4,https://ctdbase.org/detail.go?type=gene&acc=1803,,,1803.0,DPP4,9823,Sus scrofa (pig),Deoxynivalenol results in decreased expression of DPP4 mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
348,1318184,40024,Comparative Toxicogenomics Database (CTD),Deoxynivalenol,C007262,deoxynivalenol,https://ctdbase.org/detail.go?type=chem&acc=C007262,10480,EIF3M,https://ctdbase.org/detail.go?type=gene&acc=10480,,,10480.0,EIF3M,9823,Sus scrofa (pig),Deoxynivalenol results in increased expression of EIF3M mRNA,,,PMID:35307453,https://www.ncbi.nlm.nih.gov/pubmed/35307453,35307453,,
349,1306895,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,37,ACADVL,https://ctdbase.org/detail.go?type=gene&acc=37,,,37.0,ACADVL,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of ACADVL mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
350,1306896,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,79777,ACBD4,https://ctdbase.org/detail.go?type=gene&acc=79777,,,79777.0,ACBD4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in increased expression of ACBD4 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
351,1306897,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Chlorodiphenyl (54% chlorine) results in decreased activity of ACHE protein|ascorbic acid inhibits the reaction [chlorodiphenyl (54% chlorine) results in decreased activity of ACHE protein],,,PMID:16248992,https://www.ncbi.nlm.nih.gov/pubmed/16248992,16248992,,
352,1306898,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,51554,ACKR4,https://ctdbase.org/detail.go?type=gene&acc=51554,,,51554.0,ACKR4,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of ACKR4 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
353,1339071,40470,Comparative Toxicogenomics Database (CTD),"2,2',3,3',4-Pentachlorobiphenyl",D020111,Chlorodiphenyl (54% Chlorine),https://ctdbase.org/detail.go?type=chem&acc=D020111,7866,IFRD2,https://ctdbase.org/detail.go?type=gene&acc=7866,,,7866.0,IFRD2,10090,Mus musculus (house mouse),Chlorodiphenyl (54% chlorine) results in decreased expression of IFRD2 mRNA,,,PMID:23650126,https://www.ncbi.nlm.nih.gov/pubmed/23650126,23650126,,
354,1314744,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,30844,EHD4,https://ctdbase.org/detail.go?type=gene&acc=30844,,,30844.0,EHD4,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of EHD4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
355,1315365,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55531,ELMOD1,https://ctdbase.org/detail.go?type=gene&acc=55531,,,55531.0,ELMOD1,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ELMOD1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
356,1315366,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,255520,ELMOD2,https://ctdbase.org/detail.go?type=gene&acc=255520,,,255520.0,ELMOD2,10090,Mus musculus (house mouse),Decamethrin affects the expression of ELMOD2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
357,1315367,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,423245,ELMSAN1,https://ctdbase.org/detail.go?type=gene&acc=423245,,,423245.0,ELMSAN1,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ELMSAN1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
358,1315368,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6924,ELOA,https://ctdbase.org/detail.go?type=gene&acc=6924,,,6924.0,ELOA,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ELOA mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
359,1315369,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6921,ELOC,https://ctdbase.org/detail.go?type=gene&acc=6921,,,6921.0,ELOC,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ELOC mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
360,1315370,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,64834,ELOVL1,https://ctdbase.org/detail.go?type=gene&acc=64834,,,64834.0,ELOVL1,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ELOVL1 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
361,1315371,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ELOVL2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
362,1315372,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,6785,ELOVL4,https://ctdbase.org/detail.go?type=gene&acc=6785,,,6785.0,ELOVL4,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ELOVL4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
363,1316447,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2066,ERBB4,https://ctdbase.org/detail.go?type=gene&acc=2066,,,2066.0,ERBB4,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ERBB4 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
364,1316448,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55914,ERBIN,https://ctdbase.org/detail.go?type=gene&acc=55914,,,55914.0,ERBIN,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ERBIN mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
365,1316449,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,23085,ERC1,https://ctdbase.org/detail.go?type=gene&acc=23085,,,23085.0,ERC1,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ERC1 mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
366,1316450,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26059,ERC2,https://ctdbase.org/detail.go?type=gene&acc=26059,,,26059.0,ERC2,10090,Mus musculus (house mouse),Decamethrin results in increased expression of ERC2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
367,1316451,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,26059,ERC2,https://ctdbase.org/detail.go?type=gene&acc=26059,,,26059.0,ERC2,10116,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ERC2 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
368,1316452,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2068,ERCC2,https://ctdbase.org/detail.go?type=gene&acc=2068,,,2068.0,ERCC2,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ERCC2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
369,1316453,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2071,ERCC3,https://ctdbase.org/detail.go?type=gene&acc=2071,,,2071.0,ERCC3,10116,Rattus norvegicus (Norway rat),[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with allethrins] results in decreased expression of ERCC3 protein,,,PMID:34896426,https://www.ncbi.nlm.nih.gov/pubmed/34896426,34896426,,
370,1316454,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2073,ERCC5,https://ctdbase.org/detail.go?type=gene&acc=2073,,,2073.0,ERCC5,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ERCC5 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
371,1316455,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,54821,ERCC6L,https://ctdbase.org/detail.go?type=gene&acc=54821,,,54821.0,ERCC6L,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of ERCC6L mRNA,,,PMID:34520793,https://www.ncbi.nlm.nih.gov/pubmed/34520793,34520793,,
372,1317189,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,55194,EVA1B,https://ctdbase.org/detail.go?type=gene&acc=55194,,,55194.0,EVA1B,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of EVA1B mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
373,1317190,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,2121,EVC,https://ctdbase.org/detail.go?type=gene&acc=2121,,,2121.0,EVC,10090,Mus musculus (house mouse),Decamethrin affects the expression of EVC mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
374,1317191,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,132884,EVC2,https://ctdbase.org/detail.go?type=gene&acc=132884,,,132884.0,EVC2,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of EVC2 mRNA,,,PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/37019170,37019170,,
375,1317864,40585,Comparative Toxicogenomics Database (CTD),Deltamethrin,C017180,decamethrin,https://ctdbase.org/detail.go?type=chem&acc=C017180,63901,FAM111A,https://ctdbase.org/detail.go?type=gene&acc=63901,,,63901.0,FAM111A,10090,Mus musculus (house mouse),Decamethrin results in decreased expression of FAM111A mRNA,,,PMID:34520793|PMID:37019170,https://www.ncbi.nlm.nih.gov/pubmed/34520793|https://www.ncbi.nlm.nih.gov/pubmed/37019170,34520793|37019170,,
376,1312133,42131,Toxin and Toxin Target Database (T3DB),"2,3,4-Trichlorodibenzofuran",T3D2238,"2,3,4-Trichlorodibenzofuran",http://www.t3db.ca/toxins/T3D2238,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dibenzofurans bind the aryl hydrocarbon receptor, which increases its ability to activate transcription in the XRE promoter region. this alters the expression of a number of genes. (A586)",,,PMID:17252538,https://www.ncbi.nlm.nih.gov/pubmed/17252538,17252538,,
377,1312482,42669,Toxin and Toxin Target Database (T3DB),"1,2,3,4,6,8-Hexachlorodibenzo-P-dioxin",T3D2115,"1,2,3,4,6,8-Hexachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2115,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
378,1314543,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,8714,ABCC3,https://ctdbase.org/detail.go?type=gene&acc=8714,,,8714.0,ABCC3,10116,Rattus norvegicus (Norway rat),Oltipraz results in increased expression of ABCC3 protein|oltipraz results in increased expression of ABCC3 mrna|[oltipraz results in increased expression of ABCC3 protein] which affects the export of acetaminophen metabolite,,,PMID:12920174,https://www.ncbi.nlm.nih.gov/pubmed/12920174,12920174,,
379,1314544,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),Oltipraz promotes the reaction [ABCC4 protein results in increased transport of arsenic],,,PMID:25752797,https://www.ncbi.nlm.nih.gov/pubmed/25752797,25752797,,
380,1314545,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),Oltipraz results in increased expression of ABCC4 mRNA,,,PMID:20395535,https://www.ncbi.nlm.nih.gov/pubmed/20395535,20395535,,
381,1314546,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606,Homo sapiens (human),Oltipraz results in increased expression of ABCC4 protein,,,PMID:20395535|PMID:25752797,https://www.ncbi.nlm.nih.gov/pubmed/20395535|https://www.ncbi.nlm.nih.gov/pubmed/25752797,20395535|25752797,,
382,1314547,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10090,Mus musculus (house mouse),[lithocholic acid co-treated with oltipraz] results in increased expression of ABCC4 protein,,,PMID:18032408,https://www.ncbi.nlm.nih.gov/pubmed/18032408,18032408,,
383,1314548,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10090,Mus musculus (house mouse),NFE2L2 protein affects the reaction [oltipraz results in increased expression of ABCC4 mrna],,,PMID:22496397,https://www.ncbi.nlm.nih.gov/pubmed/22496397,22496397,,
384,1314549,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,10090,Mus musculus (house mouse),Oltipraz results in increased expression of ABCC4 mrna|[oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC4 mRNA,,,PMID:15833929|PMID:22496397,https://www.ncbi.nlm.nih.gov/pubmed/15833929|https://www.ncbi.nlm.nih.gov/pubmed/22496397,15833929|22496397,,
385,1314550,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,10090,Mus musculus (house mouse),[lithocholic acid co-treated with oltipraz] results in increased expression of ABCC5 protein,,,PMID:18032408,https://www.ncbi.nlm.nih.gov/pubmed/18032408,18032408,,
386,1314551,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,10090,Mus musculus (house mouse),[oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of ABCC5 mrna|oltipraz results in increased expression of ABCC5 mRNA,,,PMID:15833929,https://www.ncbi.nlm.nih.gov/pubmed/15833929,15833929,,
387,1315152,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606,Homo sapiens (human),Oltipraz results in increased expression of CYP2B6 protein|oltipraz results in increased expression of CYP2B6 mrna|oltipraz results in decreased activity of CYP2B6 protein,,,PMID:19833192,https://www.ncbi.nlm.nih.gov/pubmed/19833192,19833192,,
388,1315153,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,29277,CYP2C11,https://ctdbase.org/detail.go?type=gene&acc=29277,,,29277.0,Cyp2c11,10116,Rattus norvegicus (Norway rat),CYP2C11 protein affects the metabolism of oltipraz,,,PMID:15831204|PMID:15920769,https://www.ncbi.nlm.nih.gov/pubmed/15831204|https://www.ncbi.nlm.nih.gov/pubmed/15920769,15831204|15920769,,
389,1315154,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,266684,CYP2D1,https://ctdbase.org/detail.go?type=gene&acc=266684,,,266684.0,Cyp2d1,10116,Rattus norvegicus (Norway rat),CYP2D1 protein affects the metabolism of oltipraz,,,PMID:15831204|PMID:15920769,https://www.ncbi.nlm.nih.gov/pubmed/15831204|https://www.ncbi.nlm.nih.gov/pubmed/15920769,15831204|15920769,,
390,1315155,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606,Homo sapiens (human),Oltipraz affects the activity of CYP2E1 protein,,,PMID:10775323,https://www.ncbi.nlm.nih.gov/pubmed/10775323,10775323,,
391,1315156,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,13112,CYP3A11,https://ctdbase.org/detail.go?type=gene&acc=13112,,,13112.0,Cyp3a11,10090,Mus musculus (house mouse),Oltipraz results in increased expression of CYP3A11 mRNA,,,PMID:22496397,https://www.ncbi.nlm.nih.gov/pubmed/22496397,22496397,,
392,1315157,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116,Rattus norvegicus (Norway rat),CYP3A2 protein affects the metabolism of oltipraz,,,PMID:15831204|PMID:15920769,https://www.ncbi.nlm.nih.gov/pubmed/15831204|https://www.ncbi.nlm.nih.gov/pubmed/15920769,15831204|15920769,,
393,1315158,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116,Rattus norvegicus (Norway rat),CYP3A23-3A1 protein affects the metabolism of oltipraz,,,PMID:15831204|PMID:15920769,https://www.ncbi.nlm.nih.gov/pubmed/15831204|https://www.ncbi.nlm.nih.gov/pubmed/15920769,15831204|15920769,,
394,1315159,47318,Comparative Toxicogenomics Database (CTD),Oltipraz,C026209,oltipraz,https://ctdbase.org/detail.go?type=chem&acc=C026209,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Oltipraz metabolite results in decreased activity of CYP3A4 protein|oltipraz affects the activity of CYP3A4 protein,,,PMID:10775323,https://www.ncbi.nlm.nih.gov/pubmed/10775323,10775323,,
395,1318185,51464,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzofuran",T3D2179,"1,2,4,7,9-Pentachlorodibenzofuran",http://www.t3db.ca/toxins/T3D2179,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dibenzofurans bind the aryl hydrocarbon receptor, which increases its ability to activate transcription in the XRE promoter region. this alters the expression of a number of genes. (A586)",,,PMID:17252538,https://www.ncbi.nlm.nih.gov/pubmed/17252538,17252538,,
396,1318186,51464,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzofuran",T3D2179,"1,2,4,7,9-Pentachlorodibenzofuran",http://www.t3db.ca/toxins/T3D2179,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606,Homo sapiens (human),,,,PMID:21078588,https://www.ncbi.nlm.nih.gov/pubmed/21078588,21078588,,
397,1318187,51465,Toxin and Toxin Target Database (T3DB),"1,3,4,6,7,8-Hexachlorodibenzofuran",T3D2192,"1,3,4,6,7,8-Hexachlorodibenzofuran",http://www.t3db.ca/toxins/T3D2192,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dibenzofurans bind the aryl hydrocarbon receptor, which increases its ability to activate transcription in the XRE promoter region. this alters the expression of a number of genes. (A586)",,,PMID:17252538,https://www.ncbi.nlm.nih.gov/pubmed/17252538,17252538,,
398,1318188,51465,Toxin and Toxin Target Database (T3DB),"1,3,4,6,7,8-Hexachlorodibenzofuran",T3D2192,"1,3,4,6,7,8-Hexachlorodibenzofuran",http://www.t3db.ca/toxins/T3D2192,BE0001122,Transient receptor potential cation channel subfamily A member 1,http://www.t3db.ca/biodb/bio_entities/BE0001122,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606,Homo sapiens (human),,,,PMID:21078588,https://www.ncbi.nlm.nih.gov/pubmed/21078588,21078588,,
399,1318189,51466,Toxin and Toxin Target Database (T3DB),"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",T3D2104,"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2104,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
400,1318190,51466,Toxin and Toxin Target Database (T3DB),"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",T3D2104,"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2104,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
401,1318191,51466,Toxin and Toxin Target Database (T3DB),"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",T3D2104,"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2104,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Chlorinated dibenzo-p-dioxins cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. the affinity for the ah receptor depends on the structure of the specific CDD. the change in gene expression may result from the direct interaction of the ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. the affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. the change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of cdds. this includes 2,3,7,8-tetrachlorodibenzo-p-dioxin's carcinogenicity is thought to be the result of its ability to alter the capacity of both exogenous and endogenous substances to damage the DNA by inducing CYP1A1- and CYP1A2-dependent drug-metabolizing enzymes. (L177)",,,,,,,
402,1318192,51466,Toxin and Toxin Target Database (T3DB),"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",T3D2104,"1,2,4,6,8-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2104,BE0000337,Transthyretin,http://www.t3db.ca/biodb/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606,Homo sapiens (human),"Cdds are believed to disrupt the production, transport, and disposition of thyroid hormones. one mechanism of this involves metabolites of cdds competing with thyroxine to bind to transthyretin, decreasing serum thyroid hormone levels. this change in thyroid hormone levels has been linked to both thyroid toxicity and neurobehavioral alterations. (L628)",,,,,,,
403,1318983,54847,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",T3D2103,"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2103,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
404,1318984,54847,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",T3D2103,"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2103,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
405,1318985,54847,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",T3D2103,"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2103,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Chlorinated dibenzo-p-dioxins cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. the affinity for the ah receptor depends on the structure of the specific CDD. the change in gene expression may result from the direct interaction of the ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. the affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. the change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of cdds. this includes 2,3,7,8-tetrachlorodibenzo-p-dioxin's carcinogenicity is thought to be the result of its ability to alter the capacity of both exogenous and endogenous substances to damage the DNA by inducing CYP1A1- and CYP1A2-dependent drug-metabolizing enzymes. (L177)",,,,,,,
406,1318986,54847,Toxin and Toxin Target Database (T3DB),"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",T3D2103,"1,2,4,7,9-Pentachlorodibenzo-p-dioxin",http://www.t3db.ca/toxins/T3D2103,BE0000337,Transthyretin,http://www.t3db.ca/biodb/bio_entities/BE0000337,P02766,Transthyretin,7276.0,TTR,9606,Homo sapiens (human),"Cdds are believed to disrupt the production, transport, and disposition of thyroid hormones. one mechanism of this involves metabolites of cdds competing with thyroxine to bind to transthyretin, decreasing serum thyroid hormone levels. this change in thyroid hormone levels has been linked to both thyroid toxicity and neurobehavioral alterations. (L628)",,,,,,,
407,1306706,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,5272,SERPINB9,https://ctdbase.org/detail.go?type=gene&acc=5272,,,5272.0,SERPINB9,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB9 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
408,1306707,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,29950,SERTAD1,https://ctdbase.org/detail.go?type=gene&acc=29950,,,29950.0,SERTAD1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SERTAD1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
409,1306708,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9792,SERTAD2,https://ctdbase.org/detail.go?type=gene&acc=9792,,,9792.0,SERTAD2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of SERTAD2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
410,1306709,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,29946,SERTAD3,https://ctdbase.org/detail.go?type=gene&acc=29946,,,29946.0,SERTAD3,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SERTAD3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
411,1306710,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,143686,SESN3,https://ctdbase.org/detail.go?type=gene&acc=143686,,,143686.0,SESN3,9606,Homo sapiens (human),Epigallocatechin gallate results in increased expression of SESN3 mRNA,,,PMID:35701726,https://www.ncbi.nlm.nih.gov/pubmed/35701726,35701726,,
412,1306711,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,91404,SESTD1,https://ctdbase.org/detail.go?type=gene&acc=91404,,,91404.0,SESTD1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SESTD1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
413,1307198,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,80349,SKIC8,https://ctdbase.org/detail.go?type=gene&acc=80349,,,80349.0,SKIC8,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SKIC8 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
414,1307199,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,177343,SKN-1,https://ctdbase.org/detail.go?type=gene&acc=177343,,,177343.0,skn-1,6239,Caenorhabditis elegans,Epigallocatechin gallate results in increased expression of SKN-1 mrna|skn-1 protein affects the susceptibility to epigallocatechin gallate,,,PMID:31047916,https://www.ncbi.nlm.nih.gov/pubmed/31047916,31047916,,
415,1307552,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,7782,SLC30A4,https://ctdbase.org/detail.go?type=gene&acc=7782,,,7782.0,SLC30A4,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SLC30A4 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
416,1307553,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,1317,SLC31A1,https://ctdbase.org/detail.go?type=gene&acc=1317,,,1317.0,SLC31A1,9606,Homo sapiens (human),Epigallocatechin gallate inhibits the reaction [cisplatin results in increased degradation of SLC31A1 protein]|epigallocatechin gallate results in increased expression of SLC31A1 mRNA,,,PMID:25927922|PMID:27270317,https://www.ncbi.nlm.nih.gov/pubmed/25927922|https://www.ncbi.nlm.nih.gov/pubmed/27270317,25927922|27270317,,
417,1307554,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,1317,SLC31A1,https://ctdbase.org/detail.go?type=gene&acc=1317,,,1317.0,SLC31A1,9606,Homo sapiens (human),Epigallocatechin gallate results in increased expression of and affects the localization of SLC31A1 protein,,,PMID:27270317,https://www.ncbi.nlm.nih.gov/pubmed/27270317,27270317,,
418,1307555,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,1317,SLC31A1,https://ctdbase.org/detail.go?type=gene&acc=1317,,,1317.0,SLC31A1,9606,Homo sapiens (human),Epigallocatechin gallate results in increased expression of SLC31A1 protein,,,PMID:25927922,https://www.ncbi.nlm.nih.gov/pubmed/25927922,25927922,,
419,1307556,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,9197,SLC33A1,https://ctdbase.org/detail.go?type=gene&acc=9197,,,9197.0,SLC33A1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SLC33A1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
420,1307557,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,10559,SLC35A1,https://ctdbase.org/detail.go?type=gene&acc=10559,,,10559.0,SLC35A1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SLC35A1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
421,1307558,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,55032,SLC35A5,https://ctdbase.org/detail.go?type=gene&acc=55032,,,55032.0,SLC35A5,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of SLC35A5 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
422,1308038,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of IFIT1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
423,1308039,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,3437,IFIT3,https://ctdbase.org/detail.go?type=gene&acc=3437,,,3437.0,IFIT3,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of IFIT3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
424,1308040,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,24138,IFIT5,https://ctdbase.org/detail.go?type=gene&acc=24138,,,24138.0,IFIT5,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of IFIT5 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
425,1308041,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of IFITM1 mRNA,,,PMID:32512070,https://www.ncbi.nlm.nih.gov/pubmed/32512070,32512070,,
426,1308042,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,10410,IFITM3,https://ctdbase.org/detail.go?type=gene&acc=10410,,,10410.0,IFITM3,9606,Homo sapiens (human),Epigallocatechin gallate results in decreased expression of IFITM3 mRNA,,,PMID:32512070|PMID:35701726,https://www.ncbi.nlm.nih.gov/pubmed/32512070|https://www.ncbi.nlm.nih.gov/pubmed/35701726,32512070|35701726,,
427,1308043,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10090,Mus musculus (house mouse),Epigallocatechin gallate inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 protein]|epigallocatechin gallate inhibits the reaction [[lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mrna],,,PMID:12794164,https://www.ncbi.nlm.nih.gov/pubmed/12794164,12794164,,
428,1308044,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,163702,IFNLR1,https://ctdbase.org/detail.go?type=gene&acc=163702,,,163702.0,IFNLR1,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in increased expression of IFNLR1 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
429,1313469,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,4683,NBN,https://ctdbase.org/detail.go?type=gene&acc=4683,,,4683.0,NBN,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of NBN mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
430,1313470,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,4077,NBR1,https://ctdbase.org/detail.go?type=gene&acc=4077,,,4077.0,NBR1,9606,Homo sapiens (human),Epigallocatechin gallate results in increased expression of NBR1 mRNA,,,PMID:35701726,https://www.ncbi.nlm.nih.gov/pubmed/35701726,35701726,,
431,1313471,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,23310,NCAPD3,https://ctdbase.org/detail.go?type=gene&acc=23310,,,23310.0,NCAPD3,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of NCAPD3 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
432,1313472,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,23397,NCAPH,https://ctdbase.org/detail.go?type=gene&acc=23397,,,23397.0,NCAPH,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of NCAPH mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
433,1315892,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,84656,GLYR1,https://ctdbase.org/detail.go?type=gene&acc=84656,,,84656.0,GLYR1,9606,Homo sapiens (human),[testosterone undecanoate co-treated with levonorgestrel] results in increased expression of GLYR1 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
434,1315893,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,64582,GPR135,https://ctdbase.org/detail.go?type=gene&acc=64582,,,64582.0,GPR135,9606,Homo sapiens (human),[testosterone undecanoate co-treated with levonorgestrel] results in increased expression of GPR135 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
435,1315894,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,9687,GREB1,https://ctdbase.org/detail.go?type=gene&acc=9687,,,9687.0,GREB1,9606,Homo sapiens (human),[testosterone undecanoate co-treated with levonorgestrel] results in decreased expression of GREB1 mrna|testosterone undecanoate results in decreased expression of GREB1 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
436,1315895,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,3003,GZMK,https://ctdbase.org/detail.go?type=gene&acc=3003,,,3003.0,GZMK,9606,Homo sapiens (human),Testosterone undecanoate results in increased expression of GZMK mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
437,1315896,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,26091,HERC4,https://ctdbase.org/detail.go?type=gene&acc=26091,,,26091.0,HERC4,9606,Homo sapiens (human),Testosterone undecanoate results in decreased expression of HERC4 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
438,1315897,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,3119,HLA-DQB1,https://ctdbase.org/detail.go?type=gene&acc=3119,,,3119.0,HLA-DQB1,9606,Homo sapiens (human),[testosterone undecanoate co-treated with levonorgestrel] results in increased expression of HLA-DQB1 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
439,1315898,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161.0,HMMR,9606,Homo sapiens (human),Testosterone undecanoate results in increased expression of HMMR mrna|[testosterone undecanoate co-treated with levonorgestrel] results in increased expression of HMMR mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
440,1315899,65157,Comparative Toxicogenomics Database (CTD),Testosterone Undecanoate,C010792,testosterone undecanoate,https://ctdbase.org/detail.go?type=chem&acc=C010792,220988,HNRNPA3,https://ctdbase.org/detail.go?type=gene&acc=220988,,,220988.0,HNRNPA3,9606,Homo sapiens (human),Testosterone undecanoate results in decreased expression of HNRNPA3 mRNA,,,PMID:19074003,https://www.ncbi.nlm.nih.gov/pubmed/19074003,19074003,,
441,1316990,65663,Comparative Toxicogenomics Database (CTD),Aloxistatin,C108192,aloxistatin,https://ctdbase.org/detail.go?type=chem&acc=C108192,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein,,,PMID:32186374,https://www.ncbi.nlm.nih.gov/pubmed/32186374,32186374,,
442,1316991,65663,Comparative Toxicogenomics Database (CTD),Aloxistatin,C108192,aloxistatin,https://ctdbase.org/detail.go?type=chem&acc=C108192,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606,Homo sapiens (human),Aloxistatin promotes the reaction [indatraline results in increased expression of SQSTM1 protein]|aloxistatin promotes the reaction [sertraline results in increased expression of SQSTM1 protein]|aloxistatin results in increased expression of SQSTM1 protein,,,PMID:33124469,https://www.ncbi.nlm.nih.gov/pubmed/33124469,33124469,,
443,1317492,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [pregabalin results in increased expression of ACE protein],,,PMID:31629013,https://www.ncbi.nlm.nih.gov/pubmed/31629013,31629013,,
444,1317493,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Telmisartan results in decreased expression of ACE mRNA,,,PMID:19171132|PMID:29909460,https://www.ncbi.nlm.nih.gov/pubmed/19171132|https://www.ncbi.nlm.nih.gov/pubmed/29909460,19171132|29909460,,
445,1317494,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,10116,Rattus norvegicus (Norway rat),Telmisartan results in decreased expression of ACE protein,,,PMID:25973029,https://www.ncbi.nlm.nih.gov/pubmed/25973029,25973029,,
446,1318494,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [daunorubicin results in increased expression of EDNRA protein],,,PMID:20888384,https://www.ncbi.nlm.nih.gov/pubmed/20888384,20888384,,
447,1318495,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,10116,Rattus norvegicus (Norway rat),Telmisartan promotes the reaction [daunorubicin results in increased expression of EDNRB protein],,,PMID:20888384,https://www.ncbi.nlm.nih.gov/pubmed/20888384,20888384,,
448,1318496,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,14103,FASL,https://ctdbase.org/detail.go?type=gene&acc=14103,,,14103.0,Fasl,10090,Mus musculus (house mouse),Telmisartan inhibits the reaction [cadmium chloride results in increased expression of FASL protein],,,PMID:21620867,https://www.ncbi.nlm.nih.gov/pubmed/21620867,21620867,,
449,1318497,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [cadmium chloride results in increased expression of FASLG protein],,,PMID:21819444,https://www.ncbi.nlm.nih.gov/pubmed/21819444,21819444,,
450,1318498,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,2335,FN1,https://ctdbase.org/detail.go?type=gene&acc=2335,,,2335.0,FN1,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mrna]|telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein],,,PMID:19706694,https://www.ncbi.nlm.nih.gov/pubmed/19706694,19706694,,
451,1318499,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [AGT protein results in increased expression of FOS protein],,,PMID:33872574,https://www.ncbi.nlm.nih.gov/pubmed/33872574,33872574,,
452,1318500,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,2668,GDNF,https://ctdbase.org/detail.go?type=gene&acc=2668,,,2668.0,GDNF,10090,Mus musculus (house mouse),"Telmisartan inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein]|telmisartan inhibits the reaction [1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF mrna]",,,PMID:23747572,https://www.ncbi.nlm.nih.gov/pubmed/23747572,23747572,,
453,1318838,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Telmisartan results in decreased expression of IL6 mRNA,,,PMID:21479465,https://www.ncbi.nlm.nih.gov/pubmed/21479465,21479465,,
454,1318839,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Telmisartan inhibits the reaction [arsenite results in increased expression of IL6 protein],,,PMID:34339004,https://www.ncbi.nlm.nih.gov/pubmed/34339004,34339004,,
455,1318840,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Telmisartan results in decreased expression of IL6 protein,,,PMID:29909460,https://www.ncbi.nlm.nih.gov/pubmed/29909460,29909460,,
456,1318841,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),Telmisartan results in decreased expression of INS protein,,,PMID:15892894,https://www.ncbi.nlm.nih.gov/pubmed/15892894,15892894,,
457,1318842,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116,Rattus norvegicus (Norway rat),Telmisartan results in increased expression of INS1 protein,,,PMID:19171132,https://www.ncbi.nlm.nih.gov/pubmed/19171132,19171132,,
458,1318843,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,9606,Homo sapiens (human),[atorvastatin co-treated with telmisartan] results in decreased expression of IRAK1 mRNA,,,PMID:20524934,https://www.ncbi.nlm.nih.gov/pubmed/20524934,20524934,,
459,1318844,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090,Mus musculus (house mouse),Telmisartan affects the reaction [LEPR protein affects the abundance of ALB protein]|telmisartan affects the reaction [LEPR protein affects the expression of OCLN mrna],,,PMID:34464088,https://www.ncbi.nlm.nih.gov/pubmed/34464088,34464088,,
460,1318845,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991.0,LIPE,10090,Mus musculus (house mouse),PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein]|telmisartan results in increased expression of LIPE protein,,,PMID:20176998,https://www.ncbi.nlm.nih.gov/pubmed/20176998,20176998,,
461,1318846,65999,Comparative Toxicogenomics Database (CTD),Telmisartan,D000077333,Telmisartan,https://ctdbase.org/detail.go?type=chem&acc=D000077333,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),Telmisartan inhibits the reaction [lipopolysaccharides results in increased phosphorylation of MAPK1 protein],,,PMID:22124178,https://www.ncbi.nlm.nih.gov/pubmed/22124178,22124178,,
462,1378933,73364,Comparative Toxicogenomics Database (CTD),Calpeptin,C071482,calpeptin,https://ctdbase.org/detail.go?type=chem&acc=C071482,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,10090,Mus musculus (house mouse),Calpeptin inhibits the reaction [acetaminophen results in increased expression of and results in increased cleavage of DNM1L protein]|calpeptin affects the reaction [acetaminophen affects the phosphorylation of DNM1L protein],,,PMID:35713544,https://www.ncbi.nlm.nih.gov/pubmed/35713544,35713544,,
463,1352640,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8602,NOP14,https://ctdbase.org/detail.go?type=gene&acc=8602,,,8602.0,NOP14,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP14 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
464,1316038,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3726,JUNB,https://ctdbase.org/detail.go?type=gene&acc=3726,,,3726.0,JUNB,10116,Rattus norvegicus (Norway rat),Nitric oxide results in increased activity of JUNB protein,,,PMID:15949472,https://www.ncbi.nlm.nih.gov/pubmed/15949472,15949472,,
465,1316039,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,23028,KDM1A,https://ctdbase.org/detail.go?type=gene&acc=23028,,,23028.0,KDM1A,9606,Homo sapiens (human),Nitric oxide results in increased expression of KDM1A mRNA,,,PMID:23546878,https://www.ncbi.nlm.nih.gov/pubmed/23546878,23546878,,
466,1316040,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,9365,KL,https://ctdbase.org/detail.go?type=gene&acc=9365,,,9365.0,KL,9606,Homo sapiens (human),KL protein results in increased abundance of nitric oxide|[kl protein results in increased abundance of nitric oxide] which results in increased expression of SOD2,,,PMID:17709902,https://www.ncbi.nlm.nih.gov/pubmed/17709902,17709902,,
467,1316041,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3816,KLK1,https://ctdbase.org/detail.go?type=gene&acc=3816,,,3816.0,KLK1,10116,Rattus norvegicus (Norway rat),KLK1 protein inhibits the reaction [gentamicins results in decreased abundance of nitric oxide]|klk1 protein results in increased abundance of nitric oxide|icatibant inhibits the reaction [KLK1 protein results in increased abundance of nitric oxide],,,PMID:16401625,https://www.ncbi.nlm.nih.gov/pubmed/16401625,16401625,,
468,1316042,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827.0,KNG1,9615,Canis lupus familiaris (dog),Nitric oxide deficiency results in increased activity of KNG1 protein modified form,,,PMID:10805402,https://www.ncbi.nlm.nih.gov/pubmed/10805402,10805402,,
469,1316043,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827.0,KNG1,9606,Homo sapiens (human),KNG1 protein results in increased abundance of nitric oxide,,,PMID:10535458,https://www.ncbi.nlm.nih.gov/pubmed/10535458,10535458,,
470,1316044,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827.0,KNG1,10090,Mus musculus (house mouse),KNG1 affects the abundance of nitric oxide|pd 123319 affects the reaction [KNG1 affects the abundance of nitric oxide],,,PMID:16514058,https://www.ncbi.nlm.nih.gov/pubmed/16514058,16514058,,
471,1308232,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5310,PKD1,https://ctdbase.org/detail.go?type=gene&acc=5310,,,5310.0,PKD1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PKD1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
472,1308233,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,114780,PKD1L2,https://ctdbase.org/detail.go?type=gene&acc=114780,,,114780.0,PKD1L2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PKD1L2 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
473,1308234,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,339039,PKD1P3,https://ctdbase.org/detail.go?type=gene&acc=339039,,,339039.0,PKD1P3,9606,Homo sapiens (human),Sodium arsenite affects the expression of PKD1P3 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
474,1954228,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,1036,CDO1,https://ctdbase.org/detail.go?type=gene&acc=1036,,,1036.0,CDO1,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in increased expression of CDO1 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
475,1954229,9887054,Comparative Toxicogenomics Database (CTD),Oxaliplatin,D000077150,Oxaliplatin,https://ctdbase.org/detail.go?type=chem&acc=D000077150,1039,CDR2,https://ctdbase.org/detail.go?type=gene&acc=1039,,,1039.0,CDR2,10116,Rattus norvegicus (Norway rat),[oxaliplatin co-treated with topotecan] results in decreased expression of CDR2 mRNA,,,PMID:25729387,https://www.ncbi.nlm.nih.gov/pubmed/25729387,25729387,,
476,1935587,9941379,Drug Gene Interaction database (DGIdb),Bremelanotide,,BREMELANOTIDE,https://www.dgidb.org/drugs/rxcui:2176312,,MC4R,https://www.dgidb.org/genes/hgnc:6932,,,4160.0,MC4R,9606,Homo sapiens (human),,,,,,,,
477,1984041,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,9641,IKBKE,https://ctdbase.org/detail.go?type=gene&acc=9641,,,9641.0,IKBKE,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of IKBKE mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
478,1984042,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,64375,IKZF4,https://ctdbase.org/detail.go?type=gene&acc=64375,,,64375.0,IKZF4,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of IKZF4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
479,1984043,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,3588,IL10RB,https://ctdbase.org/detail.go?type=gene&acc=3588,,,3588.0,IL10RB,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of IL10RB mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
480,1984044,16211032,Comparative Toxicogenomics Database (CTD),Cellulose,D002482,Cellulose,https://ctdbase.org/detail.go?type=chem&acc=D002482,16157,IL11RA1,https://ctdbase.org/detail.go?type=gene&acc=16157,,,16157.0,Il11ra1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of IL11RA1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
481,1987590,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,81537,SGPP1,https://ctdbase.org/detail.go?type=gene&acc=81537,,,81537.0,SGPP1,10090,Mus musculus (house mouse),Sodium glutamate results in increased expression of SGPP1 mRNA,,,PMID:19001666,https://www.ncbi.nlm.nih.gov/pubmed/19001666,19001666,,
482,1987591,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,150094,SIK1,https://ctdbase.org/detail.go?type=gene&acc=150094,,,150094.0,SIK1,10090,Mus musculus (house mouse),Sodium glutamate results in decreased expression of SIK1 mrna|[trans fatty acids co-treated with sodium glutamate] results in increased expression of SIK1 mRNA,,,PMID:22078008,https://www.ncbi.nlm.nih.gov/pubmed/22078008,22078008,,
483,1987592,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10090,Mus musculus (house mouse),"[fats, unsaturated co-treated with sodium glutamate co-treated with aspartame] affects the expression of SIRT1 mRNA",,,PMID:23783067,https://www.ncbi.nlm.nih.gov/pubmed/23783067,23783067,,
484,1987593,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10090,Mus musculus (house mouse),[resveratrol co-treated with sodium glutamate] results in increased expression of SIRT1 protein,,,PMID:28708105,https://www.ncbi.nlm.nih.gov/pubmed/28708105,28708105,,
485,1987594,23672308,Comparative Toxicogenomics Database (CTD),Monosodium Glutamate,D012970,Sodium Glutamate,https://ctdbase.org/detail.go?type=chem&acc=D012970,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933.0,SIRT2,10090,Mus musculus (house mouse),"[fats, unsaturated co-treated with sodium glutamate co-treated with aspartame] affects the expression of SIRT2 mRNA",,,PMID:23783067,https://www.ncbi.nlm.nih.gov/pubmed/23783067,23783067,,
